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ABSTRACT
Persons with Type 2 diabetes (T2D) report fatigue, compromised strength and 
physical performance, yet studies utilizing objective measures are sparse. This study 
assessed isometric strength, contractile properties and performance in the tibialis anterior in 
6 women (50 ±5 years) and 8 men (54 ±6 years) with T2D, and 6 gender-, age- and activity- 
matched women (50 ±7 years) and 4 men (55 ±4 years). Muscle fatigue was examined 
using a 75 % intermittent protocol. HbA1c and blood glucose were higher in T2D, but 
strength, contractile properties and physical performance did not differ. Fatigue and 
recovery were parallel between groups. When non-neuropathic individuals with T2D are 
age, gender and activity matched to controls, they are not weaker nor fatigue faster. This 
presents good news for persons who control glucose fairly well and suggests that 
neuropathy, age, gender and physical activity should be considered when assessing 
persons with strength and fatigue in T2D.
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GLOSSARY
Terms relating to Diabetes Mellitus
beta-cell
cardiopathy
diabetes mellitus
endothelial 
foot ulcer
galactitol
glucose
glycosylated haemoglobin
hypercholesterolemia
hyperglycaemia
hypertension
insulin
Pancreatic cell occurring in the Islet of Langerhans 
responsible for insulin production and secretion.
Disorder of the cardiovascular system; secondary 
disease of Type 2 diabetes where hyperglycaemia 
results in damages to the blood-carrying vessels and the 
heart.
A group of metabolic disorders characterized by 
chronically elevated blood glucose.
A single layer of cells that line blood vessels.
A sore on the underside of the foot often the result of 
neuropathy; when a wound goes unnoticed because of 
lack of sensation and becomes severe.
Used to artificially induce diabetes; is a chemical 
origination from plants and formed by reduction of 
galactose.
A monosaccharide sugar, C6H i 20 6, found in plants and 
animals. Main energy source of the body.
Haemoglobin subunit (A1) that has irreversibly attached 
to glucose by a glycosylation reaction. Important tool to 
assess glucose control over past 120 days.
Excessive presence of cholesterol in blood (above 5.2 
mmol/L) (Health Canada, 2007).
High levels of glucose (beyond 3.9 -  5.8 mmol/L) in the 
blood; a sign of diabetes (Health Canada, 2007).
Abnormally elevated blood pressure [normal less than 
120/80 millimetres of mercury [mmHg]; Stage 1 is 140- 
159 /90 -99  mmHg; Stage 2 is 160 -179 /100 -109  mmHg; 
Stage 3 greater than 180/110 mmHg (Health Canada, 
2007)].
A protein that is produced by the beta-cells of the 
pancreas important for glucose uptake into cells 
(chemical ligand).
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nephropathy
polyol pathway
retinopathy
secondary disorder
Type 2 diabetes mellitus
Degenerative disease of the kidneys; secondary disease 
of Type 2 diabetes where high levels of blood glucose 
results in impaired function of nephrons in the kidney.
Glucose enters this cycle when aldose reductase 
reduces it to sorbitol forming advanced glycation end- 
products (these can cause damage to cells).
Degenerative disease of the retina; secondary disease of 
Type 2 diabetes where increased blood glucose can 
result in destruction of the retina over time.
Refers to degenerative diseases of organ systems (e.g. 
neuropathy) that occur as the direct result of another 
condition (e.g. hyperglycaemia).
Non-insulin dependent form of diabetes; where insulin 
recognition and receptor function is impaired resulting in 
high blood glucose levels.
xv i
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II. Nerve and Muscle Physiology
action potential 
agonist
alpha motoneurone
antagonist
atrophy
central activation
central failure
co-activation 
conduction velocity 
contractile properties
demyelination 
dorsiflexion 
doublet discharge
Single electrical potential change occurring between the 
inside and outside of a nerve or muscle fibre (originating 
from the central nervous system or electrically induced). 
Successive depolarization and repolarization of cell 
membrane. Electrical message.
The contracting muscle in the agonist-antagonistic pair 
of opposing/working muscles.
Neurons originating from the central nervous system, 
which have axons that extend outside to control muscle 
(efferent).
Opposes the agonist in the agonist-antagonist pair; is the 
muscle that lengthens.
Wasting away, or decrease in tissue size from disease, 
disuse or injury.
Reflects the ability of the central nervous system to 
voluntarily initiate movement in the peripheral muscle per 
demand.
Inability of the components of the central nervous system 
(above the alpha motor neuron and muscle) to demand 
movement from muscle.
Activation (muscle activity) of the antagonist while the 
agonist is engaged in activity.
Speed of electrical message transmission (action 
potential) along a nerve.
Refers to the electrically-induced response of a muscle. 
The descriptors of that twitch are classified as contractile 
properties -  relating to muscle function and fibre type.
Destruction of the myelin sheath covering nerve axons. 
Interrupts signal transmission.
An upward turning action of the foot/hand (e.. point toes 
to the sky). Important component in efficient locomotion.
Two action potentials that are discharged by one motor 
unit close in time (less than 10 ms).
xv ii
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dynamometre An instrument used to quantify torque production.
electromyography 
electrophysiology 
end-plate potential
fast twitch (Type lla/llb)
fatigue 
fibre type
half-relaxation time
integrated electromyography
inversion
isokinetic
isometric
lactate
latency
lateral gastrocnemius
The task of recording electrical activity within a muscle; 
the result is an electromyograph.
The study of electrical phenomena concerning bodily 
function.
A potential generated on the post-synaptic membrane 
causing partial membrane depolarization, inducing an 
action potential along the sarcolemma.
A type of muscle fibre that has the ability to contract fast. 
Involved in intense, short duration activity. Includes types 
lia and lib.
Defined as a decline of the force generating capacity of 
muscle.
Classification of muscle cells by function; slow-twitch (I) 
and fast-twitch (lla/llb/llx).
Time it takes for peak torque to fall to one half of its 
maximum value. Timing characteristic to define the 
twitch.
Smoothed signal integrated over time to allow 
observation of the accumulated EMG activity overtime.
To turn over or backward (e.. turn foot laterally up to 
show foot underside).
An exercise providing variable resistance with constant 
speed, with special equipment.
Muscle contraction against resistance where muscle 
fibre length or joint angle does not change.
The end product of anaerobic glycolysis.
Tim e interval between stimulus and reaction.
A muscle on the posterior side of the lower leg.
Originates from the lateral and medial condyles of the 
femur, inserts with the soleus muscle via the Achilles 
tendon into the posterior surface of the calcaneus. 
Innervated by the tibial nerve, to cause plantarflexion of 
the foot.
x v iii
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maximum voluntary contraction 
motoneurone
motor end-point 
motor nerve 
motor unit
motor unit firing rate 
motor unit recruitment
motor unit remodelling
muscle activation 
muscle fibre 
m-wave
myofibre
myopathy
myosin
myosin heavy chain
neurodegeneration
nerve
neuromuscular junction
Greatest voluntary force generated for a muscle.
A neuron originating in the central nervous system or 
ganglion, sends impulses to a muscle.
Highly innervated region of a muscle.
Same as motoneurone.
A group of muscle fibres that are controlled and 
innervated by a single neuron = one unit.
Rate (number of impulses per unit of time) that a motor 
unit emits action potentials.
Important in modulation of force. Motor units of different 
sizes are called upon in specific order to maximize force 
production. Smallest diameter first to largest are turned 
on, and largest to smallest to turn off.
Adjacent nerve reinnervates muscle fibre when the 
commanding alpha-motoneurone dies; the muscle fibre 
takes on the characteristics of the adjacent nerve fibre 
over time.
Same as activation.
Muscle cell. Smallest functional unit of a muscle.
Compound muscle action potential; the EMG result of an 
electrical stimulus received in a muscle and the 
synchronous action potentials from varying motor units 
combine to give a general tracing.
Muscle cell; smallest functional unit of a muscle.
Disorder of muscle tissue.
Important contractile protein involved in cross-bridge 
cycling in muscle contraction.
Com ponent of myosin.
Deterioration of elements of the nervous system.
Ensheathed bundle of neurons (axons).
Junction where alpha-motoneurone and sarcolemma 
meet.
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neuron Nerve cell. Smallest functional unit of the nervous 
system.
neuropathy
oscilloscope 
peak torque
peroneal nerve
rate coding 
reinnervation
resting membrane potential
slow twitch (Type I)
supramaximal twitch
surface electromyography 
synaptic vesicle
synergist
Degenerative disease of the nervous system; secondary 
disease occurring in type 2 diabetes from prolonged 
exposure to high levels of glucose. Diagnosed clinically 
by nerve conduction studies.
Device used to show changes in voltage or current.
Characteristic of the twitch; the greatest amount of force 
produced from an electrical impulse elicited along a 
nerve to a muscle.
Nerve innervating the tibialis anterior; derived from the 
dorsal branches of the fourth and fifth lumbar and the 
first and second sacral nerve. Divides into the superficial 
and deep peroneal nerve.
Refers to when the intensity of a stimulus increases the 
firing rate.
The subsequent process by which a muscle loses nerve 
stimulation and regains it, usually by adjacent nerve 
input.
Charge separation established by sodium and potassium 
pumps across a membrane in living cells; source of 
stored or potential energy. Usually measures -70 mV.
Slow oxidative; capillary, mitochondria and myoglobin 
dense (red colour). More oxygen can go into it to sustain 
long bouts of aerobic activity. Also denoted as Type I.
A twitch that is elicited by incrementally increasing 
voltage to obtain a maximal size twitch, then increasing 
the voltage a subsequent 10 %.
Type of electromyography (EMG) where signals are 
collected by surface electrodes.
In axon of neuron, carries neurotransmitters that are 
stored and released at the pre-synaptic membrane into 
the synaptic cleft (between pre and post membranes).
A muscle that aids the agonist in movement.
xx
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tetanus 
tibialis anterior
time to peak tension
torque
twitch
twitch interpolation
Completely fused twitches, elicited by continuous 
electrical stimulation.
Muscle that covers the tibia, originates in the lateral 
surface of the tibia, inserts into the medial cuneiform and 
first metatarsal of the foot; contraction will dorsiflex/ 
invert foot.
Characteristic of a twitch, the time it takes to generate 
maximal force during a twitch.
Rotational force; equals force times perpendicular 
distance. Units are Nm.
Muscle response to single electrical impulse, causes 
change in the force tracing.
Technique that assesses whether a muscle is fully 
activated. Based on the premise that if muscle is 
completely engaged through voluntary effort, an 
electrical impulse (makes twitch along nerve and 
muscle) will not cause an increase in force.
xxi
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I. Outcome Measures
4-metre walk
Activities-balance confidence 
scale
activities of daily living
Berg Balance Scale
Diabetes Self-Efficacy Scale
Test of functional mobility; exemplifies ability to 
walk/walking speed in daily living.
Questionnaire that yields information about personal 
confidence concerning balance in daily living.
Daily tasks and actions that a person is or may be 
involved in during a normal day that relates to their 
personal autonomy.
Functional balance test that assesses balance 
capabilities in daily living context.
A clinical questionnaire assessing a person’s 
perception/ability/confidence to care for his/her 
diabetes.
Michigan Neuropathy Screening 
Instrument
mobility
A set of questions relating to/defining the existence of 
neuropathy
Ability to move safely without hindrance.
Semmes-Weinstein Monofilament A nylon filament/bristle that bends at a predetermined
force (i.e. 10 g). Important in sensory testing of nerves.
Short-form 36
Step-test exercise prediction of 
submaximal V 0 2
Timed "up and go"
V 0 2 max
Waterloo Footedness 
Questionnaire
Yale Physical Activity Survey
A subset of the Medical Outcomes Survey consisting 
of 36 questions. It yields information relating to health 
perception.
Submaximal predicted test of oxygen consumption 
involving stepping exercise
Test of functional mobility, gives information about 
walking speed.
Maximum amount of oxygen, in millilitres [ml_], that a 
person can use in one minute per kilogram of 
bodyweight.
A set of questions designed to determine leg 
dominance.
A set of questions that yield information to quantify the 
amount of activity a person is involved in daily/weekly.
xx ii
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CHAPTER I
INTRODUCTION 
Type 2 Diabetes Mellitus in Society
Diabetes mellitus refers to a group of metabolic disorders of the endocrine system, 
where hyperglycaemia (an elevation in blood glucose concentration) is a hallmark outcome. 
According to the Canadian Diabetes Association [CDA] (2003), more than two million 
Canadians are affected with some form of diabetes. It has been estimated that Type 2 
diabetes [T2D] (also known as non-insulin dependent diabetes mellitus) has a 90 % 
prevalence rate within the general population (CDA, 2003) and traditionally the age of onset 
is late adulthood. It has been suggested that changes in lifestyle and nutrition patterns, 
particularly in developed nations, will largely contribute to an exponential rise in T2D (Said 
& Bril, 1999). Consequent to the onset of T2D, patients often self-report muscle weakness 
and reduced function (Sayer, Dennison, Syddall, Gilbody, Phillips, & Cooper, 2005). The 
reduction in physical function alone causes a staggering financial burden on our health care 
system (Katzmarzyk, Glendhill, & Shephard, 2000; O ’Brien, Patrick, & Caro, 2003).
Currently, there is no cure for T2D (Pontiroli, 2004), but existing treatment involves 
modifications of diet, reduction of body fat, exercise prescription, pharmaceutical 
intervention and insulin therapy in some cases (Bailes, 2002). Although many components 
of the aetiology of T2D have yet to be elucidated, it is believed to result from the interaction 
of complex genetic and environmental factors (Ostenson, 2001). Sedentary lifestyles along 
with a lack of exercise are environmental factors that are not only additive but also have the
1
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potential to influence the onset and progression of this disease when combined with 
increases in adiposity and decreases in lean body mass (Skinner, 2005).
Chronic hyperglycaemia in T2D is suspected to result from insulin resistance in 
hepatic, skeletal and adipose tissues and impaired insulin secretion from the beta cells of 
the pancreas, or a combination of both (Silverthorn, 1998). During disease progression, 
catabolic enzymes are subsequently upregulated, contributing to increases in fat, 
carbohydrate and protein breakdown (Ostenson, 2001; Silverthorn, 1998). As a direct 
result, an increase in glucose flux through metabolic pathways {i.e. sorbitol pathway) results 
in impaired homeostatic function and disease progression via the excessive formation of 
toxic by-products (Ivy, Zderic, & Fogt, 1999). Of particular importance to any discussion of 
T2D is its constellation, metabolic syndrome. The definition of metabolic syndrome has 
been redefined in recent literature as clinical perspectives and experimental ideas merge. 
Although its definition is multi-factorial, the contributing elements emerge and oftentimes 
contain the diagnosis of T2D. According to the International Diabetes Federation, metabolic 
syndrome is defined as central (referring to girth) obesity (characterized with respect to 
race) plus two of the following; elevated triglycerides, decreased FIDL (“good”) cholesterol, 
increased blood pressure/diagnosed hypertension, or increased fasting plasma 
glucose/T2D (Zimmet, Magliano, Matsuzawa, Alberti, & Shaw, 2005). Thus, when 
assessing T2D and control subjects of similar physical attributes, care must be taken to 
ensure individuals with metabolic syndrome and T2D are appropriately classified.
It is nearly impossible to tell by observation whether a person has diabetes. A person 
living with abnormally high levels of blood glucose may feel “healthy” and assert “no need”
2
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to change their current lifestyle patterns because they do not experience physical signs of 
their disease. This is particularly hazardous because untreated chronic hyperglycaemia has 
the potential to manifest in numerous secondary disorders including retinopathy and 
nephropathy, cardiopathy, neuropathy (CDA, 2003) and myopathy (Marques & Santo Neto, 
2002). Although neuropathies result from other reasons, diabetes is the most common 
underlying cause of disabling neuropathy (Said & Bril, 1999). Approximately 60 % of 
persons with T2D suffer from neuropathy-related conditions (Misur, Zarkovic, Barada, 
Batelja, Milicevic, & Turk, 2004). Diabetic neuropathy refers to neurodegeneration resulting 
from the effects of chronic hyperglycaemia and the subsequent formation of advanced 
glycation end-products (King, 2001). Diabetic neuropathies are subdivided into three 
categories: most commonly diagnosed are 1) distal symmetrical polyneuropathy; 2) 
polyneuropathy, which occurs in two distinct forms characterized by either demyelination 
(asymptomatic) and/or axonal loss (symptomatic); and 3) focal neuropathies (proximal 
motor neuropathies) that occur less frequently (Brown & Asbury, 1984; Valls-Canals, 
Povedano, Montero, & Pradas, 2002). In many cases, the hyperglycaemic condition that 
leads to irreparable bodily damage remains undetected until physical harm occurs. The 
point where reversible damage becomes so severe that it becomes irreversible is 
equivocal. Many studies have been conducted on neuropathic individuals with T2D 
(Simmons & Feldman, 2002). It is important to not only focus on symptomatic individuals, 
but also those who are asymptomatic for neuropathies in order to understand diabetic 
disease progression.
Type 2 diabetes is projected to place an enormous economic burden on Canadian 
society (O’Brien et a i,  2002). Hospital and physician visits, plus drug research and
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development have been estimated to pose an annual cost of 620 million Canadian dollars 
(Katzmarzyk et al., 2000). Alas, the global response to the rise of chronic diseases, 
including diabetes, is inadequate (Yach, Hawkes, Gould, & Hofman, 2004). To reverse 
anticipated trends in world health, Yach et al. (2004) recommend more research into 
diabetes as a core task, to support policy reformation and ensure higher placement in the 
government agenda to counteract economic impediments. For this reason, it is paramount 
that a thorough understanding of T2D and its associated disability be established so that 
appropriate interventions and treatment may be provided. Skeletal and neural tissues are 
central to our ability to generate force for basic movements and locomotion. In persons 
living with T2D, the neural and muscular systems are altered due to chronic 
hyperglycaemia and consequent to secondary disorders. This creates extensive constraints 
on performance of activities of daily living, subsequently having negative consequences on 
personal autonomy and overall quality of life.
Pharmaceutical agents are being developed to control and/or mitigate 
hyperglycaemia and these advances will aid in the delay and ultimately the prevention of 
diabetic neuropathies. Within the realm of controlling hyperglycaemia, non-pharmaceutical 
interventions such as diet and exercise adaptations are advised. Exercise has been 
prescribed as the first therapy in the management of T2D, as it improves overall physical 
and mental health, decreases stress, improves immune system function, and quality of life, 
as well as increasing life expectancy. When a person performs any type of exercise, 
glucose is utilized as an energy source, enabling the extra to get “mopped up”. Moreover, 
post-exercise glucose handling is also more efficient as free fatty acid availability is reduced 
and insulin sensitivity of glucose uptake is augmented (Shojaee-Moradie, Baynes,
4
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Pentecost, Bell, Thomas, Jackson et al., 2007) from increased blood flow to the muscle, 
increased capillarization, fibre type shifts from lib to lla, biochemical changes and increased 
muscle mass representing acute and chronic changes (Ivy et al., 1999). Thus, glucose 
control is optimized during and following bouts of physical activity. Although exercise is 
promoted as a prehabilitative and rehabilitative strategy, very little is understood about 
muscle function in persons with T2D.
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CHAPTER II 
REVIEW OF LITERATURE 
Strength and Physical Function
Many people living with T2D often report muscle weakness (Andersen, Nielsen, 
Mogensen, & Jakobsen, 2004a; Andersen, Gjerstad, & Jakobsen, 2004b; Cetinus, 
Buyukbese, Uzel, Ekerbicer, & Karaoguz, 2005; Clarke, 2004), yet the cause of this 
weakness and the influence on functional activities of daily living is presently undefined. 
Possible sources of muscle weakness include neural and muscular adaptations due to 
chronic hyperglycaemia, physical inactivity and/or disuse, or combinations of these factors. 
The best method to study muscle function in T2D would involve longitudinal study of 
persons known to be at high-risk for the development and then following diagnosis of T2D. 
Due to the nature of longitudinal studies, such a study would be difficult to administer 
considering issues of poor adherence that have been previously reported (Domenech, 
Assad, Mazzei, Kronsbein, & Gagliardino, 1995). Given the plasticity of muscle and 
differences in muscle strength due to gender (Kent-Braun, Ng, Doyle, & Towse, 2002; 
Yerdelen, Uysal, Koc, & Sarica, 2006) the most appropriate, secondary method for study 
involves the investigation of a group of individuals with diagnosed T2D compared to 
individuals that are well matched by levels of physical activity, age and gender. This type of 
matching has been utilized elsewhere (Jakobi, Killinger, Wolfe, Mahon, & Rice, 2001) and 
enables scientific investigation when intervention (i.e. inducing diabetes) studies are difficult 
to administer for ethical reasons or are limited by extensive ‘on-site’ involvement of clinical 
staff.
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The final aspect of force modulation is at the level of the motor unit, through 
progressive recruitment and increases in discharge rates of already active motor units 
(Christie & Kamen, 2006; Kernell & Sjoholm, 1975). Such neural modulation enables the 
neuromuscular system to adapt to a variety of tasks from gross movements such as 
marching on the spot to more precise or fine movements such as finger-tapping. Motor unit 
firing rates have been demonstrated to change during sustained isometric contractions to 
maintain force (De Luca, Foley, & Erim, 1996), while recruitment of additional motor units 
occur to maintain force during a submaximal fatiguing contraction (Conwit, Stashuk, Suzuki, 
Lynch, Schrager, & Metter, 2000). The neural aspect of the motor unit is typically studied 
with invasive indwelling EMG procedures (Connelly, Rice, Roos, & Vandervoort, 1999; 
Jakobi & Cafarelli, 1998), where the contractile component can be assessed via production 
of voluntary and involuntary force. Twitch and tetanic contractile properties reflect a 
muscle’s ability to generate force in time as a consequence of electrical stimulation 
(McComas, 1996). In the tibialis anterior [TA] of older adults contractile properties slow and 
voluntary force is reduced in older adults compared with younger adult men (Connelly et al.,
1999). It has been suggested (Jakobi, Rice, Curtin, & Marsh, 2000) that these alterations 
impair functional mobility in older adults. Functional mobility has been described as the 
ability to move safely from one place to another by independent means (Shumway-Cook & 
Woollacott, 2001). If contractile properties slow and voluntary force is reduced in the TA, 
this would in part, explain some of the observed impairments in mobility that are directly 
related to muscle and nerve function. To date, no study has ascertained whether alterations 
in contractile properties reflect the decrease in functional mobility that is self-reported by 
persons with T2D in clinical histories.
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Changes in contractile properties in diabetes may be independent of age, as 
hyperglycaemic interference in muscle activity has been reported in studies of 
pharmacologically induced diabetes in rodent models. In the murine model, there seems 
to be a decrease in twitch tension, no change in contractile speed and an increase in the 
synaptic delay in the flexor digitorum superficial muscle after eight weeks of induced T2D 
(Fahim, El-Sabban, & Davidson, 1998). In the sternohyoid muscle of streptozotocin diabetic 
rats, contraction duration [CD], half relaxation time [HRT], twitch tension and tetanic tension 
increase, with no effect on fatigue and the tension-frequency relationship (McGuire, 
Dumbleton, MacDermott, & Bradford, 2001), causing a net increase in the capacity for force 
generation. Dietary accumulation of galactitol (a polyol pathway metabolite) induced 
experimental diabetes resulted in loss of muscle mass, damage to the myofibres, slowed 
time to peak tension [TPT], an increase in peak tension with no alterations in relaxation 
period in the extensor digitorum longus (fast-twitch) of rats (Cameron, Cotter, Robertson, & 
Cox, 1992). In the soleus muscles (slow-twitch) of these rats peak tension was unaltered, 
but HRT and CD were prolonged for both a single twitch and tetanus. Interestingly, there 
was a marked reduction in the number of fast oxidative glycolytic (Type lla) fibres (Cameron 
et al., 1992). Overall, the results from studies of contractile alterations in animal models are 
equivocal, but lend support to the notion that hyperglycaemia may alter contractile function 
in humans because changes occur in rodent muscle, albeit invariably, when exposed to 
hyperglycaemic conditions.
While animal studies provide interesting and valuable insight regarding physiological 
mechanisms, they may not provide the most accurate description of the phenomena 
involved in the development of T2D in humans. One must not only consider the biological
8
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and species differences between animais and humans, but also the differences between 
the uses of artificially induced (i.e. toxicity of drug used) versus natural diabetes (i.e. 
cumulative effects of hyperglycaemia and vascular dysfunction). Caution must be followed 
when utilizing the results of animal studies to understand human phenomena as it is 
apparent that two entirely separate diseases are studied. Animal studies, hence, may not 
completely represent the human diabetic condition due to the enormous complexity and 
interplay between factors that are involved in the actual pathogenesis of diabetes.
Post-mortem study of the fibre composition of the human TA was determined to be 
73 % Type I fibres and 27 % Type II fibres (Johnson, Polgar, Weightman, & Appleton, 
1973). It is important to note, that fibre type composition varies between muscles and 
species (Bicer & Reiser, 2004) for example, the TA in individuals with paraplegia ranges 
from 1-40 % myosin heavy chain [MHC] I with MHC I la presenting as the dominant form 
(32-96 %) and MHC llx in lesser amounts (<1-28 %) (Harridge, Andersen, Hartkopp, Zhou, 
Biering-Sorensen, Sandri, & Kjaer, 2002), whereas the MHC composition in the TA of Fisher 
rats was found to be 2.4 ± 2.1 % MHC I, 12.2 ± 6.6 % MHC lla, with dominant form MHC lib 
49.0 ± 14.8 % while muscle MHC composition varied when comparing soleus, extensor 
digitorum longus, superficial and deep digitorum longus muscles (Staron, Kraemer, Hikida, 
Fry, Murray, & Campos, 1999). It is unknown in T2D whether changes are generally muscle 
or species specific, or influenced by the agent used to induce artificial diabetes, presenting 
substantial barriers in extrapolating results from animal studies to humans. Although this 
study will not reveal direct fibre type composition of the TA in persons with T2D, contractile 
times will provide a gross measure of the general fibre type, because a relationship exists
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between fibre type and electrically induced whole muscle contractile properties (Harridge, 
Bottinelli, Canepari, Pelligrino, Reggiani, Esbjornsson, & Saltin, 1996).
Muscle volume has been related to muscular strength. When considering 
neuropathic versus non-neuropathic individuals, neuropathic persons may be weaker 
because of muscle loss. However, muscular atrophy alone, cannot fully explain the losses 
in strength that are observed in diabetes (Lesniewski, Miller, & Armstrong, 2003) or healthy 
older adults (Narici, Reeves, Morse, & Maganaris, 2004) because force decreases more 
than the size of muscle (Lesniewski et al., 2003). It has been proposed that decreases in 
muscle strength may be related to alterations in the structure and function of a- 
motoneurones (Lesniewski et al., 2003) or incomplete reinnervation of muscle after axon 
damage in a collapsed group of persons with type 1 diabetes [T1D] and T2D (Andersen, 
Stalberg, Gjerstad, & Jakobsen, 1998). Following this logic, it is possible that persons with 
T2D who have neuropathy could be different than persons who do not have neuropathy 
because a pronounced loss of muscle mass in distal groups may be greater in neuropathic 
individuals (Andersen, Gadeberg, Brock, & Jakobsen, 1997). Accordingly, Andersen et al. 
(1997) suggest a length-dependent process of peripheral neurodegeneration. In individuals 
with neuropathic T1D, muscle volume and strength decrease compared to healthy 
individuals and persons without neuropathic pathology; however, data of this sort are 
lacking for persons with T2D (Andersen et al., 1997). Moreover, this information has been 
gained from isokinetic dynam om etry to assess strength of the ankle dorsal and plantar 
flexors, knee extensor and flexors rather than isometric strength. The latter enables a 
direct assessment of an isolated muscle group with minimal contribution of antagonist and 
synergist muscles and permit quantification of isolated whole muscle contractile properties.
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Isometric contractile properties have yet to be quantified in persons with T2D and compared 
to healthy individuals.
The purpose of skeletal muscle is to produce force and necessitate movement. 
Hence, muscular strength is highly related to functional ability and consequent to 
weakness, declines in physical function ensue (Chandler, Duncan, Kochersberger, & 
Studenski, 1998). In older non-diabetic adults there is a strong relationship between 
muscular strength in the lower limbs to gait and balance (Wolfson, Judge, Whipple, & King,
1995). As well, there is evidence to suggest that mobility, balance and endurance seem to 
increase as strength is increased in older individuals (Chandler et al., 1998; Krebs, Jette, & 
Assmann, 1998; Mulrow, Gerety, Kanten, Cornell, DeNino, Chiodo et al., 1994; 
Ramsbottom, Ambler, Potter, Jordan, Nevill, & Williams, 2004; Toulotte, Fabre, 
Dangremont, Lensel, & Thevenon, 2003). Although data on these relationships is sparse in 
persons with T2D, Brandon, Gaasch, Boyette, & Lloyd (2003) have suggested that as 
strength increases, mobility improves. While losses in mobility are common in the diabetic 
condition, the mechanisms contributing to the marked loss in strength and how strength 
may be regained remain equivocal. However, electromyography [EMG] data from gait 
studies provide further support for altered neuromuscular function contributing to declines in 
mobility in T2D. Persons with diabetic induced neuropathies required more time to develop 
force during walking, and had weaker force development during braking (Meier, Desrosiers, 
Bourassa, & Blaszczyk, 2001). Petrofsky, Lee, & Bweir (2004) studied walking 
characteristics of T2D patients and noticed that persons with T2D walked slower than 
controls. Persons with T2D also seemed to use a wider stance while walking in a linear 
pathway and while turning indicating differences in locomotion patterns between T2D and
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controls. This seems to be translated into gait compensatory adaptations that occur in 
persons with neuropathy and T2D (Kwon, Minor, Maluf, & Mueller, 2003). During walking, 
they seem to employ more co-contractions of agonist and antagonist muscles at the knees 
and ankle joints during the stance phase of walking to adopt a safer and more stable 
pattern of gait likely due to impaired sensory feedback (Kwon et al., 2003). According to 
Sacco & Amadio (2003), delayed EMG responses of the thigh and leg muscles during 
treadmill walking suggest sensory and motor disturbances. Unfortunately, these studies did 
not dissociate the T2D group into those with neuropathy and those without. Thus, it could 
not be determined whether these findings were solely related to hyperglycaemia and the 
diabetic condition.
Further support for alterations in neural activity of the muscle in persons with T2D 
come from morphological and histological studies using rodent models. In the dorsiflexors 
of the mouse, there is a decrease in resting membrane potential and miniature end-plate 
potentials due to impaired sarcolemmal-Ca2+ mobilization (Fahim, Flasan, & Alshuaib,
2000), and tetanic potentiation has been found to be lower, while the neuromuscular 
junction [NMJ] shows resistance to high-frequency stimulation (Schiller & Rahaminoff, 
1989). This phenomenon is suspected to result from changes in K+ gradients along the 
sarcolemma after high-frequency stimulation (Schiller & Rahaminoff, 1989). As well, 
ultrastructural disruptions such as reduction in the number of synaptic vesicles, 
mitochondrial degeneration (Fahim  et al., 1998, 2000), decreases in electron-dense bodies 
and myelin-like figures (Fahim et al., 1998) with marked disarray of the microtubules and 
neurofilaments of the nerves have been reported in animal models and related to the 
reduction in contractile function (Fahim et al., 2000).
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In the streptozotocin rat model, the distribution of acetylcholinesterase [AChE] 
molecules in fast twitch extensor digitorum fibres is altered, resulting in a shift of the AChE 
profile from fast-type to isoforms found in slow-type muscle (Kiss et al., 2001). Such a 
concentration shift was suspected to be the result of changes in neuromuscular function 
(reinnervation), or from dysfunctional liberation of trophic factors (Kiss, Somogyi, Csermely, 
Szelenyi, & Ver, 2001). In female diabetic mice, irregularities in acetylcholine receptors 
[AChR] at the motor end-plate resulted in patchy distribution with regular junctional folds, 
with co-localization of AChR and sprouts at the nerve terminal (Marques & Santo Neto,
2002). Despite the disruptions observed in the murine model, study of the rat model of 
diabetes indicates that the NMJ remains intact, but intracellular myofibril disarray, myelin 
figures, mitochondrial swelling and cristae lysis occur (Ozaki, Matsuura, & Narama, 2001). 
As discussed earlier, the value of the experimental animal model is great for invasive study, 
but the equivocal results between mouse and rat serve to highlight species differences and 
the requirement for human study.
The muscle compound action potential (m-wave) is utilized to assess the integrity of 
the NMJ and is a useful tool to study pathophysiology of nerves (Kim, Date, Park, Choi, & 
Lee, 2005). The m-wave is induced via supramaximal electrical stimulation and results in 
synchronous summation of motor unit action potentials. The amplitude of this potential is 
m easured from start to peak and represents the temporal and spatial summation of 
individual action potentials from individual muscle fibres while the duration corresponds to 
the time required for the rising phase and lowering phase of the m-wave, and is determined 
by temporal dispersion (Kim et al., 2005). The overall m-wave will yield information on the
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number of functional motor units and is a useful tool to study pathophysiology of nerves 
(Kim et al., 2005). Currently, no study has assessed m-waves in persons with T2D to 
determine whether the NMJ is altered in humans with T2D.
Functional mobility tests enable identification of the ability to perform functional 
activities including sitting and standing, but do not show the underlying mechanisms for 
observed impairments in mobility. Alterations in functional mobility will have serious 
ramifications on overall well-being and independence. In older persons with T2D marked 
changes in postural stability and a decrease in balance occurs (Corriveau, Prince, Hebert, 
RaTche, Tessier, Maheux, & Ardilouze, 2000). Such alterations in posture and balance 
inevitably lead to loss of mobility which has been attributed to muscle weakness in older 
persons with and without T2D. Yet, in younger persons with T2D, there is no information 
available on functional mobility and muscle strength. Leg muscles are important in 
maintaining balance and posture for all upright movements. In particular, the TA is 
important in dorsiflexion and inversion of the foot, which are integral components for 
locomotion (Mount & Dacko, 2006). An assessment of contractile properties of the TA in 
conjunction with functional mobility and balance tasks will help to understand the 
relationship between changes in mobility and balance with respect to muscle characteristics 
in persons with T2D.
It is quite possible that neuromuscular changes in diabetes do not happen until 
advanced stages of this disease, perhaps due to chronically elevated glucose levels that 
lead to secondary dysfunction (i.e. neuropathy) from ineffective disease management. Or, it 
might be possible that complex changes occur in diabetes in concert with cellular processes
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that are cued during aging. This would be consistent with studies performed on older 
persons with T2D who show functional changes different from healthy non-diabetic 
individuals (Resnick, Stansberry, Harris, Tirivedi, Smith, Morgan et al., 2002). Age-related 
alterations in the motor unit are typically evident at approximately 65 years, but do not 
manifest in functional loss of strength until 80 years or so (McNeil, Doherty, Stashuk, & 
Rice, 2005). Unequivocal within the literature concerning increasing age are the noticeable 
reductions in motor unit firing rates (Connelly et al., 1999, Jakobi & Cafarelli, 1998), with a 
decrease in the occurrence of motor unit doublet discharge during isometric force 
production (Christie & Kamen, 2006), and an increase in discharge variability resulting in 
greater fluctuations in force output in older adults (Tracy, Maluf, Stephenson, Hunter, & 
Enoka, 2005). To exclude the confounding effect of age-related change on physiology of 
the motor unit and its possible interplay with hyperglycaemia, middle-aged adults should be 
studied.
Muscle Fatigue
Muscular fatigue involves a progressive decrease in peak tension and power output 
resulting in a reduction of the overall capacity to perform muscular work (Fitts, 1996). The 
aetiology involves a complicated and multi-factorial set of integrated mechanisms, some of 
which have yet to be fully elucidated. When muscles fatigue in healthy individuals, timing of 
the twitch profile slows and there is a decrease in the peak twitch tension (Fitts, 1994, 
1996).
Disease may influence the endurance of muscle via disruptions in cellular conditions. 
These changes may result in the premature development of fatigue (Westerblad &
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Lannergren, 2001). It is conceivable that the onset of muscle fatigue could occur earlier 
because exercise in diseased conditions may begin at a point that is closer to the maximum 
working capacity of the muscle (Westerblad & Lannergren, 2001). This may be particularly 
true concerning the altered metabolic state of tissues due to hyperglycaemia. If this is a 
valid conjecture, an experimental fatigue protocol must ensure that all subjects work at the 
same relative intensity. In older adults the time to fatigue is longer than younger individuals 
when both groups perform at the same intensity for both isometric and dynamic tasks 
(Lanza, Russ, & Kent-Braun, 2004). It is unknown how persons with T2D will respond to the 
same work intensity.
It is important to make note of the potential influence of metabolic status on 
motoneurone activation state and muscle fatigue (Duchateau, Balestra, Carpentier, & 
Hainaut, 2002). Impaired glucose metabolism will influence aerobic fatigue, due to the 
altered metabolic energy supply. To minimize differences due to glucose metabolism, an 
anaerobic submaximal intermittent fatigue protocol would be optimal. To monitor metabolic 
status, blood glucose should be measured prior to and after the fatigue protocol to observe 
the glycaemic response to exercise. As well, lactate is a by-product of anaerobic energy 
production. During exhaustive exercise, lactate is produced and accumulates within the 
tissues leading to its subsequent diffusion into the venous supply. Measures of blood 
lactate and glucose would yield a gross representation of the metabolic status of the tissue, 
and has yet to be measured in persons with T2D.
In older persons, motor unit remodelling is believed to occur and has been related to 
the selective atrophy of fast-twitch fibres allowing slow twitch fibres to predominate in a
16
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muscle (Macaluso & De Vito, 2004). Interestingly, while maximal muscle strength 
decreases during the aging process, muscular endurance is preserved. This “fatigue 
paradox” has been described as task-dependent which varies among muscle groups 
(Allman, Cheng, & Rice, 2004; Lanza et al., 2004) and is likely due to age-related motor unit 
remodelling (Lanza et al., 2004, Macaluso & De Vito, 2004). The ankle dorsiflexors in older 
persons for an isometric submaximal endurance test are more fatigue resistant (Lanza et 
al,, 2004). Since time to fatigue depends on a person’s fitness level (Garland, Walton, & 
Ivanova, 2003) and fibre type composition (Hamada, Sale, MacDougall, & Tarnopolsky,
2003), there is reason to believe that the occurrence of fatigue may be different in persons 
with T2D. Furthermore, it remains unknown whether contractile properties are altered 
during fatigue in individuals with T2D, and whether the magnitude of change reflects the 
state of diabetic condition (i.e. glucose levels). To date no study has assessed muscle 
endurance in a controlled task in persons with T2D. Prior study of Addison’s Disease, an 
endocrine disorder of the adrenal gland, has suggested that patients’ self-report of muscle 
weakness and fatigue are not measured as changes in endurance time, or contractile 
function in controlled laboratory studies (Jakobi et al., 2001). Whereas, in studies of 
chronic fatigue syndrome (Lloyd, Gandevia, & Hales, 1991), poliomyelitis (Allen, Gandevia, 
Neering, Hickie, Jones, & Middleton, 1994) and fibromyalgia (Miller, Allen, & Gandevia,
1996) decreases in muscle endurance have been related to alterations in contractile 
function.
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Objectives
The relationship between functional mobility and neuromuscular properties has yet to 
be determined in T2D. Also, little is known whether differences exist in muscle fatigue 
between non-neuropathic persons with T2D and healthy individuals. Neuromuscular studies 
are essential, as the design and execution of effective therapeutic intervention cannot be 
successful without a thorough understanding of the neuromuscular adaptations to disease.
The overall objective of this thesis is to characterize neuromuscular properties, 
functional mobility, balance and fatigue in middle-aged persons with T2D.
S pecific  G oals
A im  1: To determine whether strength, m-wave and twitch contractile properties of 
the TA are different between persons with non-neuropathic T2D from age, gender 
and activity-matched individuals.
A im  2: To study the relationship between neuromuscular properties, balance and 
functional mobility in persons with non-neuropathic T2D.
A im  3: To investigate acute fatigue and recovery of the TA in persons with non- 
neuropathic T2D.
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CHAPTER III 
DESIGN AND METHODOLOGY 
Subjects and Recruitment
Prior to participation in this study, all subjects provided written informed consent. 
This investigation was conducted in the Neuromuscular Laboratory at the University of 
Windsor in accordance with the Declaration of Helsinki (The World Medical Association 
General Assembly, 2004) and the guidelines established by the University of Windsor 
Human Research Ethics Board (Appendix A). Volunteers were recruited through 
advertisements in local pharmacies, the University of Windsor Cardiac Rehabilitation 
Program, the St. Denis Centre (fitness centre), advertisements in local newspapers, and 
mass campus email (Table 1; Appendix B). All procedures were thoroughly explained by 
the investigator prior to obtaining consent (Appendix A).
S ub jec t In c lu s io n  C riteria . Volunteers were able to walk independently without pain or 
assistive devices, free from orthopaedic, neurological or mental disorders, were not 
pregnant, of sound general health, and demonstrated a willingness to participate in this 
study to be included. D iabetes Group. All persons with diagnosed T2D completed 
glycosylated haemoglobin [HbA1c] testing in the lab (A1c Now Multi-test System, Metrika 
Inc., Sunnyvale, CA) as a screening test to indicate glucose control over the past 120 days 
(HbA1c less than 8 % is considered optimal) (Appendix C). HbA1c is considered a useful 
tool for diabetes management, and diabetes-risk screening (Edelman, Olsen, Dudley, 
Harris, & Oddone, 2004). C on tro l G roup. All matched individuals for control were free from 
a history of diabetes mellitus (according to subject reported information from their personal
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physician), and also underwent HbA1c testing to ensure no chronic elevations in blood 
glucose over the past three months (excluded if HbA1c >7 %). All controls were age, 
gender and activity matched to persons with T2D.
S ub jec t E xc lus io n  C riteria . Volunteers were excluded if they had serious musculoskeletal 
disorders, injury, neurological diseases unrelated to diabetes, severe cardiovascular 
disease or history of heart attack, electrical implants (i.e. cardiac pacemaker), recovering 
from surgery, acute focal neuropathy and acute painful neuropathies (Braune, 1997), 
myopathies (Braune, 1997; Roos, Rice, Connelly, & Vandervoort, 1999), bilateral 
orthopaedic pathologies of the lower limbs (Roos et al., 1999), lower extremity dysfunctions 
or extreme physical activity patterns.
Table 1. A list of recruitment tactics showing the number of attempts made, estimated 
contact and the total number of persons recruited with T2D from July 2005 to June 2006.
Recruitment Strategy Attempts Made Distribution Rate Responses
Posters -7 5 Not applicable [n/a] 5
Windsor Star Saturday 
Edition News
1 207,163 5
University of Windsor 
DailyNews
1 4,000 1
Campus mass email to 
Faculty/Staff
2 2,339 1
Diabetes educator 
groups
-1 3 n/a 0
Word of Mouth n/a n/a 6
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Session One: Experimental Protocol and Arrangement
L abo ra to ry  Fam ilia riza tion . Subject familiarization with the study and experimenters 
occurred on the first visit to the laboratory. During this visit, subjects were asked to 
complete consent forms, background questionnaires, physical performance tests and 
sensory testing.
Q uestionna ires. Subject Contact Sheet (Appendix C) and Background Questionnaire 
(Appendix C) were used to collect general personal and contact information. The YPAS 
was administered in order to assess physical activity patterns and for subject matching 
(DiPietro, Caspersen, Ostfeld, & Nadel, 1993) (Appendix C) and the Waterloo Footedness 
Questionnaire [WFQ] (Elias, Bryden, & Bulman-Fleming, 1998) (Appendix C) was used to 
determine leg dominance. The RAND 36-item Health Survey 1.0 [SF-36] (Appendix C) was 
utilized to assess physical functioning, bodily pain, role limitations from health problems, 
and role limitations from emotional or personal issues, emotional well-being, social 
functioning, energy/fatigue and perception of general health. The Diabetes Self-Efficacy 
Scale [DSES] (Appendix C) was employed to yield information about personal confidence 
with respect to living and caring for their diabetes. The Activities-specific Balance and 
Confidence scale [ABC scale] (Powell & Myers, 1995) (Appendix C) assessed balance 
confidence while performing daily activities.
P hys ica l P erfo rm ance Tests. To quantify functional mobility and balance, a series of 
simple physical performance tests were utilized including the Berg Balance Scale [BBS] 
(Appendix D) to measure balance capability, Timed “up and go” test [TUG] (Podsiadlo & 
Richardson, 1991) (Appendix D) and the 4-metre timed walk [4m walk] (Guralnik, Fried,
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Simonsick, Kasper, Lafferty, 1995) (Appendix D) to assess walking speed and the Step 
Test Exercise Prediction [STEP] to obtain information about heart rate responses to 
exercise, and to estimate submaximal oxygen uptake (Petrella, Koval, Cunningham, & 
Paterson, 2001) (Appendix D).
S creen ing  fo r  D iabe tic  N europathy. Screening for diabetic peripheral neuropathy was 
conducted by sensory testing using a 10-gram [g] Semmes-Weinstein monofilament 
(Neuropen, Owen Mumford Ltd., Brook Hill, Woodstock, UK) by application to the dorsum of 
the great toe between the interphalangeal joint and cuticle of the nail using brief (1 second 
[s]) vertical, even pressure. The subjects were blinded and asked to respond to whether 
they felt the pressure by saying “yes”. This test was repeated 10 times with a + 8/10 
response as no indication of neuropathy or a 0-7 positive indication of neuropathy (Padua, 
Saponara, Ghirlanda, Aprile, Padua, Pauri et al., 2001) (Appendix C). The Michigan 
Neuropathy Screening Instrument [MNSI] (Appendix C) was used in conjunction with the 
aforementioned sensory testing to confirm the existence of peripheral neuropathy 
(Feldman, Stevens, Thomas, Brown, Canal, & Greene, 1994). Control subjects were also 
tested to maintain consistency between groups and to assess non-diabetic related sensory 
abnormalities
Session Two: Experimental Protocol and Arrangement
E xperim enta l A rra n g e m e n t Measures of contractile function and muscle endurance 
occurred during the second visit to the laboratory. To reduce the potential ergogenic effects 
of caffeine on the generation of peak force and muscle fatigue, the subjects were asked to
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abstain from consumption of caffeine for at least 2 hours prior to the second session of the 
study (Kalmar & Cafarelli, 1999). All tests were performed on the TA of the non-dominant 
leg except in three instances where knee impairment (n=2) or previous muscle injury (n=1) 
prevented study of the non-dominant leg. The subject was seated in a custom-built 
isometric dynamometer with the ankle of the non-dominant leg positioned to 30° of plantar 
flexion, and the hip and knee joints positioned at 90°. To minimize hip flexion, a seat-belt 
was utilized to maintain seated position during dorsiflexion. A series of two straps were 
used to restrict movement at the region of the dynamometer footplate during isometric 
contractions. Force measurements were collected by a commercial load cell attached to the 
underside of a metal footplate (Model MLP-500-T, Transducer Techniques, Inc., Temecula, 
CA). Signals were amplified and filtered (60-Hertz [Hz] notch filter), sampled at 1000 Hz 
(Model V72-25A, Coulbourn Instruments, Allentown, PA) and displayed on an oscilloscope 
in real-time for the subject to observe during the study session for feedback of their 
movements. Signals from the load cell were subsequently converted from analog to digital 
format using a 12-bit analog to digital [A/D] converter (Model 1401, Cambridge Electronic 
Design, Ltd., Science Park, Cambridge, UK) and displayed on a computer monitor. Offline 
quantification was completed using Spike 2 version 5 (Cambridge Electronic Design, Ltd., 
Science Park, Cambridge, UK). The load cell was calibrated with known weights to confirm 
consistent linear recordings over trials.
Surface Electromyography. Surface electromyography [sEM G] signals of the TA  and 
lateral gastrocnemius [LG] were obtained using self-adhering, disposable electrodes (4 
millimetres [mm]). The TA ground electrode was positioned over the patella, while the 
reference electrode was placed over the distal tendon of the TA. The active electrode was
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then positioned 1 centimetre [cm] distal to the motor end point of the TA. The motor end 
point was located using continuous single pulses (100 microsecond [ps] single square 
waves) by applying increasing current to the surface over the TA until an obvious response 
or muscle twitch was noted. To record co-activation of the antagonist LG muscle, the 
ground electrode was placed over the patella, while the active electrodes were placed 1 
centimetre [cm] apart over the mid belly of the LG. Surface electromyography signals were 
amplified (1.0 Hz) and filtered (13-1000 Hz) (Model V75-04, Coulbourn Instruments, 
Allentown, PA) and converted from analog to digital by a 12-bit A/D converter (Model 1401, 
Cambridge Electronic Design, Ltd., Science Park, Cambridge, UK) and displayed on a 
computer monitor. Offline quantification was completed using Spike 2 version 5.
Tw itch C ontractile  P roperties. Contractile properties were elicited percutaneously using 
an electrical stimulator (Model DS7AH, Digitimer Ltd., Welwyn Garden City, Hertfordshire, 
UK) and a hand-held custom made electrode bar (4 cm length). The peroneal nerve was 
palpated along the lateral side of the tibial tuberosity of the non-dominant leg. Contractile 
properties were measured by evoking single twitches at a frequency of 1 Hz with a pulse 
duration of 100 ps. Stimulation intensity was determined by increasing current intensity 
until a plateau of m-wave was observed (Figure 1). The stimulation current was then 
increased 10 % to ensure supramaximal twitch responses. Force and sEMG signals were 
monitored on a computer screen during each session and quantified offline. Measurements 
of electrically-induced contractile properties consisted of: peak twitch torque [PT], TPT and 
HRT (Figure 2). PT, TPT, and HRT were obtained from the average of 8-12 twitch force 
profiles. M-wave characteristics assessed were latency, motor nerve conduction velocity, 
and peak to peak amplitude. Latency was measured from the end of the stimulus artefact to
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the rising phase of the m-wave. Motor nerve conduction velocity was calculated using the 
distance from the centre of the stimulating electrode to the active recording electrode in 
metres [m] divided by the latency (in seconds) (Figure 3). M-wave latency, conduction 
velocity and peak to peak amplitude data were calculated from the average of 8 -1 2  muscle 
compound action potentials.
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Figure 1. M-wave and twitch growth following successive stimulation of the tibialis anterior. 
The top portion of the graph shows the incremental growth and subsequent plateau of the 
m-wave, while the bottom portion shows twitch growth and plateau.
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Time to Peak Torque (TPT)
P eak T o rq u e  (PT)
Half Relaxation Time (HRT)
Time (ms)
Figure 2. A single twitch showing Pt (Newton-metre [Nm]), TPT (milliseconds [ms]) and 
HRT (ms).
Latency Period
Onset of la tency; End of latency
Peak to peak amplitude
>
Stim ulus
artefact
Time (ms)
Figure 3. A single m-wave showing latency (ms) and peak to peak amplitude (V)
M axim um  V o lun ta ry  C on trac tion  and  Tw itch In te rpo la tion . To assess isometric 
voluntary strength subjects were instructed to force their toes upwards as hard and as fast 
as possible (dorsiflexion of the tibialis anterior) and maintain the position for 5 s while
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
provided with visual feedback from an oscilloscope and strong verbal encouragement 
(maximum voluntary contraction, [MVC]). To familiarize subjects with this effort three MVCs 
were performed prior to testing. Subsequently, the interpolated twitch technique was utilized 
to assess central drive to the TA, where the presence of a superimposed twitch on the force 
record indicates a lack of motivation or central failure. This technique involves application 
of a maximal electrical stimulus over the surface of the peroneal nerve prior to, during and 
after an MVC (Figure 4). This measure was calculated as the torque amplitude from the 
superimposed twitches (Ts) compared with a resting twitch (Tr) obtained after the MVC trial:
% Muscle Activation = [1- (Ts/Tr)] x 100 (A)
3 second contractionRest
= electrical impulse
5 minute rest
Time (s)
Figure 4. An MVC effort showing twitch interpolation at positions 1 (reference twitch), 2 and 
3 (supramaximal twitches) and 4 (resting post-twitch).
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Three MVCs separated by approximately 3 minutes of rest were performed. Force and 
sEMG signals were monitored on a computer screen during each session and quantified 
offline. The peak force generated during each MVC trial, in addition to the corresponding 
muscle activation was calculated and the best attempt was used as the MVC.
Fatigue Task. Blood glucose and blood lactate were measured before and at the end of the 
fatigue protocol as a gross indication of metabolic activity using a blood glucose monitoring 
system (Appendix C) (Ascencia Contour 7152, Bayer Healthcare LLC, Mishawaka, IN) and 
a standard blood lactate test metre (Appendix C) (Lactate Pro, Arkray Factory, Inc., Kouka- 
Gun, Shiga, Japan). The 75 % submaximal intermittent fatigue test was administered via, 
the subject being instructed with the use of prompts from an oscilloscope to exert a given 
muscle force with a work to rest ratio of 6 to 4 s, respectively. The protocol involved five, 75 
% MVC efforts and one MVC every minute [min] until the end task criterion was met (MVC 
force decreased to 75 % of muscle force). Consistent, strong verbal encouragement from 
the experimenter and visual feedback from an oscilloscope were provided to each subject 
during the fatigue task. The stimulation intensity utilized for the fatigue protocol was the 
level of optimal tetanic force production. Fused tetanic contractions were obtained by 
sequentially increasing current intensity and ensuring voltage compliance (200-300 ms) to 
obtain fused tetanus by delivering a burst of 16-50 ps wide pulses at a rate of one pulse 
every 20 ms (50-Hz). The tetanic contraction occurred once per each minute cycle. 
Central drive was assessed using the modified twitch interpolation technique (Connelly et 
al., 1999), and muscle activity was assessed with sEMG. Electrically-induced contractile 
properties were obtained from single and double pulses administered at pre-determined 
times throughout the protocol (Figure 5).
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Electfic.il event
Single pulse
Double pulse
One-Minute Cycle
Figure 5. A 75 % submaximal, modified Bigland-Ritchie fatigue protocol showing regions of 
stimulation and pulse numbers over a one minute cycle. The cycle was repeated until the 
target MVC (shown in black) becomes 75 % of the original force produced in the pre-fatigue 
condition. Submaximal 75 % MVC target efforts are shown as grey shaded blocks.
R ecovery  from  Fatigue. Muscle recovery was assessed with electrically-induced 
contractile properties, central activation, force and sEMG at 1, 3, 5 and 10 minutes after 
fatigue was declared. Each subject was instructed to perform a single 75 % contraction, 
MVC and 75 % contraction for 6 s with 4 s of rest separating each contraction (Figure 6).
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Electrical event
Single pulse
«-------------  30-second cycle -----------------►
Figure 6. Depiction of the recovery cycle performed at 1, 3, 5, and 10 minutes post-fatigue. 
Solid black box represents a 100 %MVC target force, while shaded boxes represent 75 % 
target force.
Data A na lys is . Time to fatigue was noted as the number of fatigue cycles completed until 
the end-task criterion was obtained (MVC reached 75 %MVC force). Force and sEMG 
signals were monitored on a computer screen during each session and quantified offline. 
The peak force generated during each MVC per cycle, in addition to the corresponding 
muscle activation was calculated and normalized to the first MVC (100 %). Twitch PT, HRT 
and TPT were normalized to the pre-fatigue values. Surface electromyography signals 
were full-wave rectified and integrated [iEMG] over 0.5 s intervals for the middle 2 s of the 
M VC  and first 75  % effort after the M VC  in each cycle of fatigue and recovery. The M VC  
and 75 % iEMG for each cycle were normalized to the first MVC performed in the fatigue 
task .
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Statistical Methods
Independent t-tests were utilized to determine differences between persons with 
Type 2 diabetes and matched controls with respect to the dependent variables of 
anthropometry (age, weight, waist to hip ratio), activity scores (YPAS), balance confidence 
(ABC Scale Score, %), balance ability (BBS, out of 56), self-perceived health status, 
diabetic neuropathy (Monofilament test, out of 10; MNSI, out of 15), walking ability (TUG 
score, 4m walk score, SPWT score), exercise score (STEP score), HbA1c (%), blood 
glucose (millimoles per litre, [mmol/L]) and lactate (mmol/L). As well t-tests were conducted 
on baseline measures of twitch contractile properties at baseline (PT, TPT, HRT), MVC, 
central activation and m-wave measures (latency, conduction velocity, peak to peak 
amplitude).
Dependent variables of contractile properties, force, central drive and iEMG from the 
fatigue task were compared between T2D and controls with two-way (2 groups x 7 levels) 
analysis of variance [ANOVA] tests. Comparisons were made for the start, middle, and end 
of fatigue and at 1, 3, 5 and 10 minutes post fatigue.
Linear regression analysis was conducted to determine the strength of the 
relationship between resting blood glucose and HbA1c, HbA1c and conduction velocity, PT 
compared to TU G  score and fast pace S TE P  predicted V 0 2 max com pared to M VC  scores 
in persons with T2D and healthy individuals.
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CHAPTER IV 
ANALYSIS OF RESULTS 
Physical Performance and Health Related Questionnaires
Six women (50 ± 5 years) and 8 men (54 ± 6 years) with diagnosed T2D, as well as 
a group of healthy age, gender and activity matched women (6; 50 ± 7 years) and men (4; 
55 ± 4 years) served as control in this study. Age, weight, height and waist to hip ratio were 
similar between T2D and control (Table 2). Persons with T2D had significantly higher blood 
glucose (8.33 ± 2.21 mmol//L, P=0.001) and HbA1c (8.4 ± 1.3 %, P= 0.00002) levels 
compared with the control group (5.50 ± 0.95mmol/L; 6.1 ± 0.4 %). Persons participating in 
this study were living with diagnosed T2D ~5.2 ± 4.4 years. Only one participant (living with 
T2D) was a smoker. Ninety-three percent of the diabetic persons considered themselves as 
overweight, whereas all of the controls believed they were overweight. Physician diagnosed 
hypertension (43 %) and hypercholesterolemia (71 %) were prominent in T2D. However, in 
the controls 20 % reported hypertension and hypercholesterolemia. There were no reports 
or indication of foot ulceration at the time of the study, and 86 % of the T2D subjects 
reported a next of kin (parent, grandparent, and sibling) history of diabetes. Sixty-four 
percent of T2D subjects reported metformin as the primary method of glucose control while 
21 % used insulin, and 14 % utilized dietary modifications (Table 2).
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Table 2. Anthropometric data of subjects with T2D and control individuals. Values are 
represented as mean ± standard deviation.
Characteristic T2D Control P value
Age (years) 52.6 ±6 .2 51.7 ± 6 .9 0.73
Weight (kilogram [kg]) 102.0 ± 18.6 99.2 ± 18.7 0.72
Height (cm) 172.6 ± 12.0 170.4 ± 6 .3 0.60
Waist to Hip Ratio 0.94 ± 0.09 0.92 ±0 .07 0.47
Glucose (mmol/L) 8.33 ±2.21 5.50 ±0 .95 0.001
HbA1c (%) 8.4 ± 1.3 6.1 ± 0 .4 0.00002
Years since diagnosis 5.2 ± 4 .4 n/a n/a
Smoker n=1 n=0 n/a
Weight perception
Overweight 
Underweight 
Healthy Weight
n=13
n=0
n=1
n=10
n=0
n=0
n/a
Hypertension (physician diagnosed) n=6 n=2 n/a
Hypercholesterolemia (physician diagnosed) n=10 n=2 n/a
Foot Ulcers n=0 n=0 n/a
Family History of T2D (next of kin)
CMnc n=1 n/a
Primary medications for T2D control
Metformin
Insulin
Diet
n=9
n=3
n=2
n/a n/a
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Blood glucose had a weak negative relationship to conduction velocity (Figure 7) 
while HbA1c was not related to conduction velocity (Figure 8). Blood glucose and HbA1 
showed a good positive relationship (Figure 9).
14
O 1 2  
£ u
g
aT 10 
<0 o o 
3 
05 
T3 O O
3
0)
(0
0)
X
?(t>
8
6
4
2
0
y = -0.0533X + 10.747 
R2 = 0.1573
♦♦
30 40 50 60 70 80
Conduction velocity (m/s)
90 100
Figure 7. The relationship between conduction velocity and resting blood glucose.
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The control and diabetes groups were similar in total weekly energy expenditure 
(P=0.37), number of hours of daily activities performed (P=0.45), number of flights of stairs 
climbed (P=0.43) and average walking speed (P=0.37). Stair climbing time from the STEP 
exercise test was similar between groups (P=0.93) and the resting heart rate and post heart 
rate response for the normal (P=0.73) and fast (P=0.40) stepping task did not differ (Table 
3). In both groups heart rate increased significantly from rest for the normal and fast paced 
exercise tasks (T2D normal p=7.5 x 10'11, fast p=7.5 x 10"10; Control normal p=7.9 x 10"5, 
fast p=5.4 x 10"4) indicating the cardiovascular system was challenged.
Persons with diabetes had significantly lower (P=0.03) functional balance scores 
(53.1 ± 1.8) compared with the controls (54.6 ± 1.1), yet the perception of personal 
confidence in balancing (ABC scale) was similar between groups. Even though the people 
with T2D showed no difference in the majority of the performance tests, data from the SF- 
36 showed that they perceived their health to be worse than controls in terms of how their 
emotional and physical health have affected their social roles (family, work, friends). 
Overall, persons with diabetes had poorer scores reflective of their emotional and general 
health (Table 4). On a 10 point scale, persons with T2D scored 7.0 ± 2.4 for the DSES, 
which measures confidence with respect to the education they received from clinicians and 
educators in caring for their health (Table 4). Both T2D subjects and controls received low 
neuropathy screening scores, indicating an unlikely presence of neuropathy (M N SI) or 
neuropathy of the peroneal nerve (monofilament score) (Table 4).
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Table 3. Functional mobility, balance and daily activity scores. Values are represented as
mean ± standard deviation.
Measure T2D Control P value
Energy Expenditure (kcal/week) 9098.6 ± 10101.2 6113.6 ±2313.4 0.37
Activity Score (hours/week) 37.6 ±41.2 27.2 ± 10.1 0.45
Number of Flights Climbed 8.7 ±6.2 6.7 ±5.4 0.43
Resting heart rate (BPM) 73.0 ±9.3 72.6 ± 11.7 0.93
TUG (s) 9.6 ±2.1 8.9 ± 1.3 0.37
Berg Balance Scale (/56) 53.1 ± 1.8 54.6 ± 1.1 0.03
Stair Time (s) 
Normal Pace 84.0 ± 14.0 80.4 ±28.8 0.69
Fast Pace 59.0 ±10.8 54.5 ±12.7 0.42
Post-Exercise HR (BPM) 
Normal Pace 118.1 ± 13.7 120.5 ± 18.8 0.73
Fast Pace 127.9 ± 16.6 135.7 ±23.3 0.40
Predicted Submaximal VO2 
(mL/kg/min)
Normal Pace 25.3 ±4.4 27.3 ±6.1 0.37
Fast Pace 30.9 ±5.0 33.2 ±2.4 0.27
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Table 4. Health related questionnaire scores. Values are represented as mean ± standard
deviation.
Measure T2D Control P value
ABC Scale Score 88.2 ± 15.2 89.5 ± 13.0 0.83
SF-36 (%): Role Limitations
Emotional problems 69.0 ±40 .2 100 ± 0 0.02
Physical Health 54.8 ±41 .6 92.5 ± 16.9 0.01
SF-36 (%)
Emotional Well-being 74.6 ±21 .0 91.2 ± 5 .9 0.02
General Health 53.2 ± 18.5 76.5 ± 16.5 0.004
DSES 7.0 ± 2 .4 n/a n/a
MNSI (/15) 4.5 ± 1.7 4.1 ±2.1 0.62
Monofilament Score (/10) 9.8 ± 0 .4 9.9 ±0 .17 0.21
Isometric Muscle Strength: Voluntary and Involuntary Components
Twitch contractile properties and muscle strength were similar between persons with 
T2D and controls and both groups were equally able to activate the TA muscle (Table 5). 
M-wave latency, conduction velocity and peak to peak amplitude were similar between 
groups, indicating no change in peroneal nerve function or alterations in contractile 
properties as a result of hyperglycaemia for these persons with T2D  com pared to controls 
(Table 5).
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Table 5. Voluntary and involuntary force results for persons with T2D compared to matched 
controls. Values are represented as mean ± standard deviation.
Measure T2D Control P value
Twitch Contractile Properties
Peak Torque (Nm) 4.1 ± 1.5 3.9 ± 1.3 0.66
Time to Peak Torque (ms) 94.8 ± 11.3 100.3 ± 13.0 0.36
Half-relaxation time (ms) 114.5 ±22 .9 105.8 ±20 .0 0.49
M-wave
Latency (ms) 0.003 ±0.001 0.002 ± 0.001 0.08
Conduction Velocity (m/s) 63.1 ± 17.5 73.6 ± 14.9 0.14
Peak to Peak Amplitude (V) 1.7 ±2 .0 0.85 ±0 .24 0.20
MVC
Peak Torque (Nm) 39.6 ± 9 .6 34.3 ± 7.6 0.19
Central Activation (%) 98.8 ± 3.4 100.0 ± 0 0.26
Twitch: MVC ratio (Torque) 0.11 ±0 .03 0.12 ±0 .04 0.43
A series of regressions were completed between functional mobility scores (BBS, 
TUG, STEP) compared to MVC strength and PT. TUG scores and PT showed a positive 
relationship in control (R2=0.6964) but not T2D (R2=0.011) groups (Figure 10). As well, 
STEP Predicted Submaximal V02 (fast pace) and MVC showed a negative relationship in 
control (R2=0.6745) but not in T2D (R2=0.0081) groups (Figure 11).
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Muscle Fatigue
Pre-exercise glucose (8.3 ± 2.2; 5.5 ± 0.9 mmol/L) and post exercise glucose levels 
(7.7 ± 2.0; 5.2 ± 0.9 mmol/L) were significantly different (P=0.001; P=0.001) between T2D 
and controls, albeit the magnitude of the increase in blood glucose was similar between 
groups (P=0.72). Pre-exercise blood lactate (3.8 ±5.1;  2.2 ± 1.1 mmol/L) and post-exercise 
blood lactate (4.6 ± 5.3; 2.2 ± 1.3 mmol/L) did not differ between groups (P=0.33; P=0.16), 
and increased in the T2D group but not in the control group after the fatigue task. The 
magnitude of change in blood lactate was not different between groups (P=0.72) (Table 6).
Table 6. Submaximal fatigue time to failure and gross estimates of metabolic change. Each 
value represents the mean plus standard error bars.
Measure T2D Control P value
Fatigue Time (minutes) 4.9 ±2 .5 7.9 ±5.1 0.07
Blood Glucose (mmol/L)
Pre-exercise 8.3 ±2 .2 5.5 ±0 .9 0.001
Post-exercise 7.7 ±2 .0 5.2 ±0 .9 0.001
Total change (decrease) 0.61 ±0.88 0.27 ± 0.72 0.31
Blood Lactate (mmol/L)
Pre-exercise 3.8 ±5.1 2.2 ± 1.1 0.33
Post-exercise 4.6 ± 5.3 2.2 ± 1.3 0.16
Total change (increase) 0.78 ±7.14 0.01 ± 1.03 0.72
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Time to fatigue ranged 2 - 1 1  minutes for T2D, and 3 - 2 0  minutes for controls 
(Figure 12). The average duration of the fatigue task was slightly longer in the control 
group (p=0.07) (7.9 ±5.1 minutes) compared with T2D (4.9 ± 2.5 minutes) (Table 6).
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Figure 12. MVC force achieved during the fatigue exercise over time, expressed as a 
percentage of the pre-fatigue MVC. Performance of persons with T2D is shown as solid 
lines and control group as dotted lines.
Central activation did not differ between groups, and was near maximal for the 
duration of the fatigue protocol (Figure 13). Although force decreased significantly by the 
middle of the fatigue task (85 %) and slightly more by the end of the task (77 %) it was 
similar between groups. Force did not recover in either group to the pre-fatigue values 10
42
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
minutes after the exercise bout (Figure 13).
120 n3
D)
VS
CO 100 -LL
2
CL
80
'w'
d)
>
■c 60a
16 40L.4-1
c
<u
O // ,
cQ /
O 0 -
>s
*
.....
✓r-rr^f
4  Activation 
Muscle force
*  *
Diabetes 
A- Control
/ — i---------r_
Pre Mid End R1 R3 R5 R10
Time (minutes)
Figure 13. MVC performance and muscle activation (central drive) over time during the 
fatigue and recovery tasks. The MVC force (Nm), was normalized to the MVC obtained 
prior to fatigue and expressed on a time scale as start or pre- (0), middle (50) and end 
(100). The recovery phase is shown in minutes at 1 (R1), 3 (R3), 5 (R5) and 10 (R10) 
minutes post-fatigue declaration. Each value represents the mean plus standard error bars. 
The top lines represent central drive while the bottom lines represent the normalized MVC 
force (* represents a statistically significant difference from pre-fatigue, where P<0.05).
Peak torque was significantly different from pre-fatigue at the middle and end, and 
declined to approximately 58 % midway through the fatigue task (P<0.05), although it did 
not fall significantly between the middle to the end of the fatigue task. At 10 minutes post-
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fatigue, there was a significant recovery of twitch PT to approximately 75 % of the pre­
fatigue value (Figure 14).
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Figure 14. Single twitch peak torque (Nm) performance during fatigue and recovery for the 
T2D and control groups during the fatigue and recovery tasks. All Pt values obtained were 
normalized to the pre-fatigue peak torque. Each value represents the mean plus standard 
error bars. *lndicates significant difference from pre-fatigue.T2D differed from controls 
significantly along the fatigue and recovery tasks.
Over the duration of the fatigue task contractile properties did not slow. TPT was 
similar between groups for the fatigue and recovery tasks. At 5 and 10 minutes post-fatigue, 
TPT was significantly shorter than the pre-fatigue value (approximately 88 and 85 %, for 5 
and 10 minutes, P>0.05) (Figure 15). HRT was similar between groups during the fatigue 
and recovery task (Figure 16).
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Figure 15. Single twitch time to peak torque (ms) values for the T2D and control groups 
during the fatigue and recovery tasks. All TPT values obtained were normalized to the pre­
fatigue peak torque. Each value represents the mean plus standard error bars. 
* Represents significant difference (P<0.05) from pre-fatigue value.
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Figure 16. Single twitch half-relaxation time (ms) values for the T2D and control groups 
during the fatigue and recovery tasks. All HRT values obtained were normalized to the pre­
fatigue peak torque. Each value represents the mean plus standard error bars. 
* Represents significant difference (P<0.05) from pre-fatigue value.
Integrated electromyography was similar between the T2D and control groups. 
Submaximal iEMG increased significantly during the fatigue protocol and remained 
elevated from pre-fatigue values for the 10 minutes of recovery. Maximal iEMG was similar 
between groups and did not change for the fatigue task, yet there was a slight decline in 
both groups during recovery (Figure 17).
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Figure 17. IEMG expressed as a percentage of the pre-fatigue MVC. The top lines 
represent the iEMG obtained for the 100 % MVC performance during the fatigue and 
recovery protocol and the bottom lines represent the 75 % MVC iEMG normalized to the 
pre-fatigue MVC iEMG. Each value represents the mean plus standard error bars. 
* Represents significant difference (P<0.05) from pre-fatigue value.
47
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER V 
DISCUSSION
Subjects and Recruitment
This is the first case-control investigation to measure isometric contractile properties 
and relate muscle strength and contractile activity to functional mobility in persons with 
T2D. In addition to characterization of the above mentioned properties in persons with T2D, 
the specific objectives of this study were to compare these findings to a control group of 
non-diabetic persons who were matched for both physical attributes and physical activity 
levels. Age, gender, body size and physical activity are strong factors in functional mobility 
and strength (Kent-Braun et al., 2002; Wolfson et al., 1995; Yerdelen et al., 2006), yet very 
few studies match for age and gender (Corriveau et al., 2000; Meier et al., 2001) and no 
study of persons with T2D has considered physical activity a key factor in muscle 
performance or functional mobility. In conjunction with the standard series of 
questionnaires utilized in clinical studies, functional mobility, balance, and cardiorespiratory 
function were assessed with objective laboratory tests.
Initially, a proposed objective was to investigate two groups of persons with T2D; 
those with peripheral neuropathy and those without neuropathy. This would have enabled 
the independent effect of neuropathy to be assessed with respect to neuromuscular 
properties and functional mobility in persons with T2D . However, no persons with 
neuropathy volunteered for this study. It was extremely challenging to recruit T2D 
volunteers to participate in this study; highlighting the importance of hospital and clinic 
investigators in becoming involved with university research, and indicating poor community
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relationship and interest with research in this particular region. Interestingly, all of the 
persons who volunteered to participate in this project were “healthy” diabetics with extreme 
interest in understanding their condition and prolonging function. Despite numerous and 
various tactics to “excite” potential volunteers, or evoke interest in the community, a number 
of attempts to recruit volunteers (Table 1) failed to attract more than twenty persons with 
T2D over a one year period in the Windsor-Essex region. This may be related to the lack of 
direct university interaction with a clinical hospital or endocrinology specialists. Most 
studies on contractile and neural function in persons with T2D have been conducted in 
clinical research hospitals (e.g. Andersen et al., 1997, 1998, 2004a, 2004b; Corriveau et al.,
2000).
All volunteers of the T2D population studied were free from neuropathy (Table 4) as 
determined by self-report based upon physician consultation as well as standardized 
questionnaires and physical screening (Feldman et al., 1994; Valk, De Sonnaville, Van 
Houtum, Heine, Van Eijk, Bouter et al., 1997). Determination of health history, daily and 
physical activity, resting heart rate and predicted submaximal V02 (Table 3) also 
established that the T2D and control groups did not differ and because the controls were 
representative of others in their general age category in terms of mobility speed (Podsiadlo 
& Richardson, 1991), physical activity scores, resting heart rate (King, Everett, Mainous, & 
Liska, 2006), and predicted submaximal V02 (Petrella, Koval, Cunningham, & Paterson, 
2003) we can infer that the T2D w ere also ‘healthy’ outside the diabetic state. Moreover, 
the significant difference in HbA1c and glucose between groups and the mean (8.4 ± 1.3 %; 
8.33 ± 2.21 mmol/L, T2D and 6.1 ± 0.4 %; 5.50 ± 0.95 mmol/L, controls) data are similar to
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standardized values for T2D diagnosis (CDA, 2007) substantiates that one group was 
healthy T2D and the other healthy age, gender and activity matched controls.
Strength and Physical Function
Although the persons with T2D had higher baseline blood glucose levels and HbA1c 
levels (Table 6), they performed similarly in tests of isometric strength and retain the ability 
to maximally activate the TA when sufficient practice is given (Jakobi et al., 2001). 
Irrespective of the condition of diabetes, the muscle strength data in this study was similar 
to prior reports in the dorsiflexors (Vandervoort & McComas, 1986). As well, twitch 
contractile properties, peroneal nerve conduction velocity, and m-wave profiles were similar 
between groups and comparable to the literature. Because electrically induced contractile 
properties provide a strong indication of fibre type (Gorelick & Brown, 2007) and an indirect 
assessment of Ca2+ dynamics during the cross bridge cycle (McComas, 1996) it is highly 
unlikely that hyperglycaemia has induced fibre type or contractile function adaptations in 
this healthy group of T2D subjects. Neuromuscular junction activity also seems to be 
unaltered at this stage of diabetes, as evidenced by similar m-wave peak to peak 
amplitude. Since human studies on contractile function are sparse, a continuum of change 
due to disease progression is not possible. The data describing personal attributes of this 
particular group of individuals suggests that they collectively represent “active” and 
“healthy” people (Table 3, 4  & 5) at the beginning of the disease continuum considering the 
age of diagnosis, HbA1c and glucose levels (Table 2). Thus, this study is the first to 
quantify contractile measures in the early state of T2D. In order to clearly establish the 
progressive, but deleterious effect of hyperglycaemia, it is necessary to conduct a long-term
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study where contractile properties are monitored from diagnosis through loss of functional 
independence.
Strength data from this study might differ from prior studies due to the stage of 
disease progression at the time of study, as strength studies have investigated individuals 
that are neuropathic and/or older adults. Van Schie, Vermigli, Carrington, & Boulton, (2004) 
observed a decrease in strength in neuropathic individuals, compared to controls and 
others have reported differences between neuropathic and non-neuropathic individuals 
(Andersen et al., 1997; Andreassen, Jakobsen, & Andersen, 2006). It also seems that 
many studies have included groups of older neuropathic individuals; this leads to the 
question of whether the natural physiological process of aging exacerbates the deleterious 
effect of hyperglycaemia reported in the animal literature (Cameron et al., 1992; Fahim et 
al., 1998; McGuire et al., 2001) and in extreme states where glucose is ill-controlled 
(Resnick et al., 2002). Had healthy older adults (less than 75 years) with T2D been 
assessed the possible interrelationship between the diabetic condition and natural aging 
might have been possible to clarify. Moreover, differences between this study and others 
might have occurred due to the isometric measures of strength. Most studies utilize manual 
muscle testing (Van Schie et al., 2004), grip tests (Sayer et al., 2005) or isokinetic 
dynamometry (Andersen et al., 1997, 1998; Andreassen et al., 2006; Park, Goodpaster, 
Strotmeyer, De Rekeneire, Harris, Schwartz et al., 2006) to assess muscle strength. 
Isometric force m easures and utilization of the twitch interpolation technique facilitates the 
study of an isolated muscle where minimal equipment is required and the movements are 
readily learned and executed (Jakobi et al., 2001). Manual muscle testing, hand 
dynamometry and isokinetic measures of strength are subjective measures that are
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dependent upon whole body extrapolation. Furthermore, it is difficult to establish when 
maximal performance has been learned and attained.
Physical activity was carefully monitored and matched between T2D and controls. 
Although a few studies have matched for age and gender (Corriveau et al., 2000; Meier et 
al., 2001), no study to date has matched for physical activity. This is an important task as 
strength and mobility are related to physical activity, and a major determinant of functional 
mobility differences may be accounted for by participation in daily activity or exercise 
(DiPietro et al., 1993). When daily physical activity is matched, muscle strength was not 
different between persons with T2D and non-diabetic controls, indicating that the diabetic 
condition does not result in muscle weakness.
The human literature is unclear with respect to the relationship between conduction 
velocity and hyperglycaemia. 0rskov, Worm, Schmitz, Mengel, & Sidenius (1994) 
observed conduction velocity slowing, whereas Cappellari, Airaghi, Capra, Ciammola, 
Branchi, Levi-Minzi et al. (2005) observed no remarkable changes in conduction velocity. 
In this study, neither blood glucose (Figure 7), nor HbA1c (Figure 8) were found to be well 
correlated with peroneal nerve conduction velocity. The relationship may have escaped 
detection in this study because the magnitude of change in peroneal nerve conduction 
velocity is significantly greater in individuals with HbA1c greater than 8.5 % (Huang, Chen, 
W eng, Lee, Tseng, & Huang, 2005). The glucose and HbA1c levels in the T2D groups 
were less in this study compared to others where relationships with conduction velocity 
have been observed. It is likely that detectable differences in peroneal nerve function occur 
in association with the onset of neuropathies due to chronic hyperglycaemia, because
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studies that include neuropathic individuals report difference in peroneal nerve function 
(Resnick et al., 2002). Thus, when glucose is carefully controlled peroneal nerve activity is 
not altered due to hyperglycaemia; rather alterations in conduction velocity are associated 
with development of neuropathies secondary to the diabetic condition.
These groups were well matched for all aspects of physical performance, daily 
activity, and exercise participation, but functional balance was lower in T2D (53.1 ± 1.8) 
compared with the controls (54.6 ± 1.1). Albeit a significant difference exists between the 
groups, both scores are high (scored out of 56) suggesting no balance deficits (Powell & 
Myers, 1995). Although balance was still good, the difference noted in the diabetic group 
could be indicative of an early decline in neural function or blood flow prior to the outward 
presence of foot ulcerations or loss of sensation because perception of balance confidence 
did not differ between groups (Table 4). It has been found that posture, gait and balance 
change in both T2D and T1D (free from neuropathy) (Nicholson, King, Smith, & Darlington,
2002) possibly due to changes in the vestibulo-ocular and opto-kinetic reflex (Petrofsky et 
al., 2004; Petrofsky, Lee, Macnider, & Navarro, 2005a; Petrofsky, Lee, & Cuneo, 2005b). It 
is known that balance is modulated by musculoskeletal, visual and vestibular networks and 
because strength and contractile properties were similar between groups it is highly unlikely 
that the loss of balance in these persons with T2D was due to musculoskeletal adaptations. 
No finite tests were conducted on the vestibular and visual system but, a few volunteers (4 
with T2D) used corrective lenses, however, it is unknown when use of corrective lenses 
began. It is unknown, and difficult to elucidate in most instances whether the reason for 
wearing corrective lenses was related to T2D, but it is known that T2D may be manifested 
in secondary disease of the ocular system.
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Regression analysis revealed a relationship between PT and TUG walking speed for 
controls (R2=0.6964), yet in the T2D group there was virtually no association (R2=0.011). 
Similarly, a relationship between predicted V 0 2 max from fast paced stepping was related 
to MVC in controls (R2=0.6745), but was unrelated in the T2D group (R2=0.0081). It is 
possible that knowledge of having a disease translates to performance that is impacted by 
self-perception or confidence (Stewart, Turner, Bacher, DeRegis, Sung, Tayback et al.,
2003). The individuals with T2D reported poorer perceptions of their health compared to 
controls (Table 4). Because V 0 2 max and walking speed on the TUG are subjective to each 
individuals effort it is possible that the T2D group did not reach peak values because of a 
conviction that their physical/emotional health limited performance, whereas the attainment 
of maximal on the subjective measure of performance resulted in a strong relationship with 
objective measures of contractile function (PT, isometric strength) in the non-diabetic group.
Muscle Fatigue
Clinical reports from patients not only suggest muscle weakness but also fatigue 
(Adriaanse, Dekker, Spijkerman, Twisk, Nijpels, Van der Ploeg, et al., 2005). To-date no 
study has assessed muscle fatigue and recovery in T2D. In this study T2D and control 
subjects underwent a modified isometric submaximal fatiguing exercise. This fatigue 
protocol which utilizes a 6:4 work to rest ratio has been employed for the study of muscle 
endurance in disease elsew here (Jakobi et al., 2001). However, for this study the work level 
was increased to 75 %, rather than utilizing the traditional 50 % (Bigland-Ritchie, Furbush, 
& Woods, 1986). A higher intensity was chosen because the phosphagen and anaerobic 
energy systems are primarily utilized for short duration intense activity, thus the
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contributions from aerobic metabolism; albeit active, were less in a 75 % work intensity 
protocol compared with the traditional 50 % protocol. It was necessary to minimize aerobic 
production of ATP because glucose levels are substantially higher in T2D compared with 
controls, thus the effect of the aerobic system whereby carbohydrates are the primary 
source of energy would have created an artificial ‘carbohydrate loaded’ condition. Pilot 
studies indicated time to fatigue for the 50 % work intensity was 20-30 minutes, whereas for 
the 75 % condition pilot data suggested time to fatigue would be 50 % less (8-12 minutes), 
and the intensity was of sub-maximal level that would be tolerated by volunteers. The 
neuromuscular components assessed during the fatigue protocol were voluntary force, 
twitch interpolation, twitch contractile properties and muscle activity through surface iEMG. 
Recovery was also studied through the utilization of identical measures to the fatigue task 
in order to understand the re-establishment of homeostatic set-points in the diseased 
versus the control group.
When exposed to an acute bout of a fatiguing exercise, the groups performed 
similarly with respect to time to fatigue (4.9 ± 2.5 min T2D; 7.9 ±5 .1  control) at the same 
relative work intensity. Maximal activation was assessed for the entire duration of the 
fatiguing exercise with the twitch interpolation technique and central drive was maintained 
in both groups. As suggested by these data, the decline in force was not due to an inability 
to perform an MVC in either group. Collectively, the data from this study does not support 
clinical reports of fatigue in persons with T2D . It is possible that due to the anaerobic  
nature of the fatigue protocol, the mechanism whereby fatigue occurs earlier in the diabetic 
group was circumvented. Furthermore, fatigue might be due to alterations in aerobic 
metabolism. The T2D group had higher pre- and post-exercise glucose levels compared to
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controls, but the magnitude of change from pre to post fatigue was similar between groups. 
This suggests that the ‘carbohydrate’ contribution to aerobic metabolism was similar 
between groups. Because differences occur in specific enzymatic function at various steps 
in biochemical pathways which are influenced by glucose concentrations it is plausible that 
aerobic function may change in T2D (Bouche, Serdy, Kahn, & Goldfine, 2004). The 
magnitude of change for pre and post-exercise blood lactate did not differ between groups 
(P=0.72), but it seems that the change was ‘observably’ greater in T2D, possibly indicating 
a greater emphasis on anaerobic metabolism. Since the limiting factor in aerobic 
metabolism is oxygen availability, the trend to greater lactate production could be indicative 
of limited oxygen perfusion in muscle, while this limitation may be consequent to early 
systemic microvascular changes (Rask-Madsen & King, 2007). Overall, these ‘gross’ 
metabolic measures suggest that future studies should assess muscle fatigue in persons 
with T2D and compare between aerobic and anaerobic exercises. These comparisons 
might elucidate the mechanism to support the clinical reports of fatigue in persons with 
T2D.
Twitch tension decreased to -5 0  % in both groups, and this rate of decline was 
similar between groups, and to studies of women with Addison’s Disease or older adults 
(Jakobi et al., 2000; 2001). Changes in contractile timing were similar between groups, but 
slowing did not occur during the fatigue protocol. It is likely that slowing was not present in 
this study because the duration of the fatigue protocol was too short to induce contractile 
slowing of the twitch; however, had tetanic force been studied contractile slowing might 
have been evident. Twitches are less reliable (ICC 0.83) and much more affected by fatigue 
than higher frequency responses (ICC 0.95) and thus 50 Hz contraction times are often
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utilized to assess rates of whole muscle activity (Edwards, Hill, Jones, & Merton, 1977; 
Wiles, Young, Jones, & Edwards, 1979). An attempt to measure 50 Hz tetanic contractions 
was made; however due to technical difficulty in maintaining consistent electrode 
placement, the contractile responses were unpredictable. This was determined by 
monitoring of stimulus artefact and electrical EMG responses. Overall, stimulated 
contractile measures indicate that Ca2+ kinetics through the cross-bridge cycle and fibre 
composition are unaltered in humans, as a consequence of hyperglycaemia. The animal 
literature is equivocal with respect to fibre type changes (Fahim et al., 1998; McGuire et al., 
2001) but it seems that the more heterogeneous a muscle the less apt it is to change 
proportion as a result of induced diabetes (Cameron et al., 1992).
Muscle activity was characterized by surface iEMG, and did not differ between 
groups over the duration of the fatigue protocol. Consistent with other intermittent isometric 
fatigue studies (Bigland-Ritchie et al., 1986; Jakobi et al., 2000; 2001) submaximal iEMG 
increased and maximal iEMG remained relatively constant during the fatiguing exercise. 
This rise in submaximal iEMG is the result of motor unit recruitment and increases in 
discharge rate (Conwit et al., 2000). Although both groups of subjects demonstrated this 
increase in submaximal iEMG it is known that at some point during a fatigue continuum 
submaximal iEMG will meet maximal iEMG (Bigland-Ritchie et al., 1986; Jakobi et al., 2000;
2001) and this is the point of physiological muscle ‘exhaustion’. The T2D group and control 
group did not reach this point; however, the increase in the submaximal iEMG corresponds 
to the end-point of force loss (~80 %).
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There are no reports in the literature with respect to recovery subsequent to a 
fatiguing exercise in persons with T2D. These data suggest that when force decline is 
similar there is no difference in rate of recovery between persons with T2D and age, gender 
and activity matched controls. However, in this middle-aged group of men and women 
voluntary force production remained significantly depressed at 10 minutes post-fatigue. It is 
likely that lack of recovery may be partially attributed to muscle drive. Although, central 
drive as assessed with the twitch interpolation technique indicated that the muscle was fully 
active, the maximal iEMG suggested that neural activity was slightly depressed during 
recovery. Overall, the diminutive disparity between the central activation data and the 
iEMG data can be accounted for by the twitch interpolation data reflecting a very brief 
moment (~0.5 s) of the MVC, whereas the EMG measures were averaged over the duration 
of the 6 s contraction.
Together, these results indicate that when persons with T2D are age, gender and 
physical activity matched to control subjects muscle strength, contractile function and 
fatigue is unaltered. On the other hand, these persons experience psychosocial or 
emotional consequences of being “diseased” as evidenced through self-report. Evidence 
from this study serves to highlight the importance of preventing secondary disease 
progression associated with chronically high levels of blood glucose. Functional deficits 
that have been reported previously in the literature (Dolan, Liu, Criqui, Greenland, Guralnik, 
Chan et al., 2002; Gregg, Mangione, Cauley, Thompson, Schwartz, Ensrud et al., 2002; 
Volpato, Blaum, Resnick, Ferrucci, Fried, & Guralnik, 2002) may be linked to poor 
glycaemic control that results in secondary diseases (i.e. neuropathies) over time, or 
functional decline may be exaggerated by the complex interplay of the physiological
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process of aging. This study clearly measured strength and function in non-neuropathic 
adults prior to an age where physiological changes of aging would be of primary concern 
(McNeil et al., 2005). This study purports that clinical self-reports of muscle weakness, 
fatigue and functional decline are likely related to the psychological impact of diagnosis of a 
‘disease’. In such cases, it is critical that these people receive accurate feedback on their 
disease from practitioners in addition to appropriate social support. The issue is not denying 
the condition exists, but focusing and conveying that impaired glucose control in itself does 
not indicate immediate functional change and that persons with T2D are as ‘able’ as non­
diabetic age, gender and activity matched controls. These results are good news for those 
individuals who are challenged with glucose management.
Conclusions
This study represents the first attempt to incorporate measurements of 
isometric contractile properties, strength, functional mobility and fatigue in persons with 
T2D, who are age, gender and activity matched to controls. To-date there has been no 
attempt to utilize physical activity as a component of subject matching. Because, exercise 
and physical activity are an integral component of muscle strength (Dreyer, Schroeder, 
Hawkins, Marcell, Tarpenning, Vallejo et al., 2006) and functional mobility (Scott, Votora, 
Scanlan, & Close, 2007) extreme care was taken with subject matching. Unlike many other 
studies conducted on persons with T2D , results from this experim ent indicate that when 
activity is accounted for muscle strength and fatigue are not reduced as a consequence of 
hyperglycaemia. This study provides a key example of the need to assess physical activity
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when alterations in strength and physical function are being evaluated with respect to a 
pathological condition.
The unique aspect of this study were the combined utilization of objective physical 
performance and muscle function tests with subjective measures of functional mobility, 
performance and health perception, in a group of relatively healthy, well-controlled persons 
with T2D. The combination of assessment of health perception with quantitative 
performance tests enabled elucidation of information with respect to how individuals who 
perceive their health negatively, have lower scores on subjective performance tests but do 
not differ from age, gender and activity matched controls on objective physical function 
tests that control for motivation and effort (twitch interpolation, twitch contractile properties). 
This work serves to highlight the importance of how disease perception can negatively 
impact physiological function. Moreover, these data elucidate the necessity and importance 
of early detection, glucose regulation and exercise adherence. When these are occur 
persons with T2D do not differ from age, gender and activity matched non-diabetic persons. 
This work underlines the need for clinicians to convey to persons with T2D, that this is not a 
debilitating disease, as long as glucose is controlled through physical activity in conjunction 
with standard pharmacological and diet manipulation techniques. The impact of health- 
perception and emotion on subjective physical function should not be underestimated, and 
thus reports of fatigue and weakness should be considered in conjunction with self­
perception of health.
Although there were no significant differences between T2D and controls, the overall 
message of these results is not only very important for clinicians but persons who live with
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T2D. Both populations should not underestimate how perceptions of health and exercise, 
influence physiological function. While the trend of most disease related studies is to focus 
on the critically affected to reveal significant changes from the healthy condition, and oft 
times the outcome message is negative, yet the impact of this study from well-managed 
individuals is inverse, and should not be underestimated. Hence, this study enables 
persons with T2D with a positive message of the benefit of exercise and glucose control.
Considerations for Future Research
1. Future studies should consider evaluating physical function and strength in 
conjunction with perceptions of health in persons with T2D who are neuropathic 
and in a group who undertake regular exercise at moderate to intense levels to 
understand the extent that neuropathy effects strength and function before the 
onset of age-related changes, and whether individuals who exercise are much 
different from individuals who perform moderate to little exercise (exemplified in 
this study).
2. A questionnaire with respect to self-perception of muscle fatigue and weakness 
needs to be developed and evaluated in conjunction with any future tests of 
muscle function or strength so that a direct link between self-perceived ability and 
objective m easures of function can be made.
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3. A study to assess physical function, strength and nerve function in healthy
persons without T2D who are subjected to glucose infusion to observe the acute 
effects of hyperglycaemia.
4. Since motor unit function is critical to force modulation, a study evaluating
discharge rates and recruitment during isometric force production in middle-aged 
neuropathic individuals with T2D might reveal whether losses in strength reported 
elsewhere are due to inherent changes to the motor unit when age is not a factor.
5. The results of this study suggest that individuals who have T2D do not fatigue
differently when exposed to an anaerobic fatigue task, yet a common report in 
T2D along with weakness is fatigue. An aerobic 50% submaximal intermittent 
fatigue protocol would be useful for comparison with this study and enable 
determination of muscle fatigue due to metabolic alterations that are inherent to 
T2D (i.e. glucose which is the primary substrate for aerobic metabolism).
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a) changes increasing the risk to the participant(s) and/or affecting significantly the conduct of the study;
b) all adverse and unexpected experiences or events that are both serious and unexpected;
c) new information that may adversely affect the safety of the subjects or the conduct of the study.
Forms for submissions, notifications, or changes are available on the REB website: www.uwindsor.ca/reb.
We wish you every success in your research.
Dr. Maureen Muldoon 
Chair, Research Ethics Board
cc: Dr. Jennifer Jakobi, Kinesiology
I Linda Bunn, Research Ethics Coordinator
This is an official document. Please retain the original in your files.
4 0 1  S U N S E T ' C H R Y S L E A  H A L L  T O W E R ’ W I N D S O R  O N T A R J O ’ C A N a D A  1 M
T E L E P H O N E  J I 9 /  2 J > • 1 Q 0 0 ( J ■» t 6 ) • F A X . 1 I S H  I  I ■ 3 4 4 ? ■ W E  B . »  *  •  •  w m d i  o i .  c i . ' n b
83
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
t tU N I V E R S I T Y  OF
WINDSOR
CONSENT TO PARTICIPATE IN RESEARCH
Title of study: Characterization of Neuromuscular Properties, Functional Mobility and 
Fatigue in Persons with Type 2 Diabetes mellitus
You are asked to participate In a research study conducted by Lynette Singh, Dr. Jennifer Jakobi and Dr. Kenji Kenno, from 
the Department of Kinesiology, Faculty of Human Kinetics at the University of Windsor. The results of this study will 
contribute to Lynette Singh’s thesis project to complete the candidacy for Masters of Human Kinetics (MHK) degree.
If you have any questions or concerns about the research, please feel to contact:
Lynette Singh, BScH 
Department of Kinesiology 
Faculty of Human Kinetics 
Neuromuscular Laboratory, rm 231 
University of Windsor 
Windsor, Ontario N9B 3P4 
Tel. (519) 253-3000 ext. 4049 
E-mail: singh3d@uwindsor.ca
PURPOSE OF THE STUDY
Skeletal and neural tissues are central to our ability to generate force for ail movement. In persons living with diabetes, the 
neural and muscular systems may be affected by high blood glucose. This seems to create problems with performance of 
daily tasks, affecting personal autonomy and overall quality of life. Currently, much of the information that is known about 
the neuromuscular system in diabetes comes from animal models, while information gathered from human studies is sparse. 
The goal of this study is to quantify and compare muscle properties from the tibialis anterior of healthy middle-aged adults to 
persons with Type 2 diabetes. Electrophysiological data will be compared to the results of functional mobility performance 
indicators and questionnaires to see if any relation exists between physical performance and any changes in neuromuscular 
function. This information will show how persons with Type 2 diabetes differ from healthy individuals and ultimately aid in 
understanding mechanisms of the decline in physical function. In addition, possible neuromuscular differences found during 
a fatigue protocol will be utilized to highlight changes in muscle function that may result, and could offer plausible insight to 
the muscle weakness that is experienced by some people living with Type 2 diabetes.
PROCEDURES
Day 1 -  Part A: Questionnaires and Familiarization Session
After arriving at the Neuromuscular laboratory, you will be asked to complete the Letter of Consent and receive the Letter of 
Information. Ail information gathered will be coded to ensure anonymity and will be kept confidential in a locked cabinet. You 
will be asked to complete a Background Questionnaire, the Yale Physical Activity Survey for Older Adults, the Waterloo 
Footedness Questionnaire (WFQ) and The Medical Outcomes Study (MOS) Questionnaire, the Diabetes Self-Efficacy Scale 
(OSES) and the Activities-specific Balance Confidence scale (ABC scale).
In the Multi-purpose room in the St. Denis Centre, you Will be asked to participate in a Timed-up and go (TUG), step test 
(STEP), self-paced walk (SPW), Berg Balance Scale (BBS), and the 4m timed walk test with rest periods in between.
Day 1 - Part B: Sensory Tests
To distinguish neuropathic and non-neuropathic persons, initial screening will be conducted by sensory testing using a 10-g 
Semmes-Weinstein monofilment (nylon brush) that will be applied lightly to the back of each great toe below the cuticle on 
the skin 10 times In different places. You will be asked to complete the Michigan Neuropathy Screening Instrument (MNSI) In 
addition to the initial sensory testing.
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Day 1 - Part C: Glycosylated Hemoglobin Test
All persons will receive a glycosylated hemoglobin test from a single drop of blood obtained using standard sampling 
techniques that are the same as finger prick testing used for blood glucose measurements.
Day 2: Electrophysiological Testing
Before the neuromuscular study, you will be asked to refrain from consuming caffeine for at least 2 hours prior. Blood 
glucose will be measured using a standard glucose meter. Blood lactate will be measured at the same time, using a standard 
lactate sampling technique.
You will be seated with your non-dominant leg in a device to measure force Your non-dominant leg will be secured using a 
series of straps at the foot, and padded leg clamps to keep your leg in position. At rest, a non-adhesive electrode will be 
connected to a stimulator and will be placed on the surface of the skin over your shin and utilized to assess twitch contractile 
properties. Electrical activity will be recorded by attaching self-adhering button electrodes to the skin over your shin region. In 
the first part, with the muscle at rest, your lower leg muscle over the front of your lower leg (tibialis anterior) will be maximally 
stimulated. This stimulation begins at low and progressively increases until the muscle responds without the interference of 
the calf muscles. In the second part of the neuromuscular investigation, you will be asked (in same seated position) to force 
your toes upwards as hard and as fast as possible and hold the position for 3 seconds (maximum voluntary contraction, 
MVC) and will be allowed to monitor your progress.The interpolated twitch technique involves application of a maximal 
electrical stimulus to the nerve in your leg prior to, during and after a maximum voluntary contraction (MVC). You will be 
asked to perform three MVCs separated by 5 minutes of rest. One to two MVCs will be performed before testing to 
familiarize you with the technique. In a fatigue test, you will be asked to exert muscle force in your leg until your muscle 
fatigues. At the end of this test, your blood glucose and blood lactate levels will be measured again. Day 2 will take 
approximately 1 hour to complete.
POTENTIAL RISKS AND DISCOMFORTS
There is always a risk when performing any physical activity, but the risk associated with these tests do not exceed the risk 
of performing activities of daily living. With the use of surface EMG electrodes a minimal risk of minor skin irritation exists, but 
is similar to that of wearing a bandage. A standard minimal risk (similar to "at home tests’) may be associated with blood 
work in the neuromuscular laboratory, but sterile precautions for use and disposal of lancets will be taken.
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
There is evidence to suspect that people with Type 2 diabetes are different from healthy individuals. At present, however, 
there is very little information available regarding electrophysiological characteristics of muscle in Type 2 diabetes. To date, 
no study has combined electrophysiological tests, nor assessed fatigue in conjunction with such a variety of physical 
performance tests and questionnaires to gather a gradation of information concerning how the body adapts physiologically to 
this disease.
This study provides volunteers an opportunity to participate in research that could provide information to advance current 
knowledge about diabetes, information that may help in the advancement of more suitable exercise prescriptions and 
treatment for Type 2 diabetes. Volunteers will gain a greater self-awareness from completion of questionnaires and mobility 
tests and will have an opportunity to see their glycosylated haemoglobin levels.
PAYMENT FOR PARTICIPATION
All subjects will receive a gift package containing information about general health and diabetes, sample products and a 
cookbook (total value approximately $30.00).
CONFIDENTIALITY
Any information that is obtained in connection with this study and that can be identified with you will remain confidential and 
will be disclosed only with your permission. All data from subjects will be collected and coded for anonymity at the beginning 
of the study session.
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PARTICIPATION AND WITHDRAWAL
YOU can choose whether to be in this study or not. If you volunteer to be In this study, you may withdraw at any time without 
consequences of any kind. You may also refuse to answer any questions you do not want to answer and still remain in the 
study. The investigator may withdraw you from this research if circumstances arise which warrant doing so. Any persons 
with musculoskeletal disorders, injury, other neurological disorders or painful neuropathy, myopathy, severe cardiovascular 
disease, have a pacemaker, recovering from surgery, alcoholism, pregnancy, or extreme physical activity patterns are 
unsuitable candidates for this study and will be excluded.
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
You will receive information about your glycosylated haemoglobin levels. Because this experiment Involves the use of non­
diagnostic tests, the results of each test will not be available until cumulative group averages are found. Study results will be 
published on the University of Windsor ethics website at www.uwindsor.ca/reb for you to look through at the final completion 
of the investigation.
SUBSEQUENT USE OF DATA
This data will be used in subsequent studies.
Do you give consent for the subsequent use of the data from this study? □  Yes □  No
RIGHTS OF RESEARCH SUBJECTS
You may withdraw your consent at any time and discontinue participation without penalty. This study has been reviewed and 
received ethics clearance through the University of Windsor Research Ethics Board. If you have questions regarding your 
rights as a research subject, contact:
Research Ethics Coordinator 
University of Windsor 
Windsor, Ontario N9B 3P4 
Tel. (519)253-3000 ext. 3916 
E-mail: lbunn@uwindsor.ca
SIGNATURE OF RESEARCH SUBJECT/LEGAL REPRESENTATIVE
I understand the information provided for the study Characterization of Neuromuscular Properties, Functional Mobility 
and Fatigue in Persons with Type 2 Diabetes mellltus as described herein. My questions have been answered to my 
satisfaction, and I agree to participate in this study. I have been given a copy of this form.
Name of Subject
Signature of Subject Date
SIGNATURE OF INVESTIGATOR
These are the terms under which I will conduct research.
Signature of Investigator Date
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Appendix B. Recruitment Advertisements
Researchers at the University of Windsor are looking for 
individuals WITH and WITHOUT Type 2 Diabetes to 
participate in a study to look at mobility and strength.
Volunteers between the ages of 40-65 can have a free 
glycoiated haemoglobin test.
If you are male or female between the ages of 40-65 
and would like more information
PLEASE CONTACT
Lynette Singh or Jennifer Jakobi, PhD
(519)253-3000 extension 4049
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NEEDED
Individuals between 40-65 years 
of age with and without Type 2 
Diabetes
Researchers at the University of Windsor are conducting 
a study to examine mobility and muscle characteristics in 
persons with Type 2 Diabetes
Volunteers between the ages of 40-65 can have a free 
glycolated hemoglobin test.
For further Information, PLEASE CONTACT: 
Lynette Singh or Jennifer Jakobi, PhD 
(519)253-3000 extension 4049
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WANTED
rA
o u
Researchers at the University of Windsor are 
looking for individuals to participate in a study to 
look at mobility and strength.
If you are male or female between the ages of 40-65 
and would like more information
PLEASE CONTACT
Lynette Singh or Jennifer Jakobi, PhD 
(519)253-3000 extension 4049
0
«  24 
® o>
•7 to
*6) §
C CO 
<fi CO
I S ®
t-s7 t o  Z
SZ O  
0)0 c  CO
£9 co
*5. 72.
J  S  x
o>!
c  I
©
©
o>;c
£0 co  
£ to _CM C»6T q
T”to 3
JC o  
CD o
£ co
w  CO
0 to e  cm© STc
- 7 1 0
JCD)
W co 
0
—  22 
© 05 o
1 5  2 I w  X
JC OO) o  
.5  co
w  CO0 to _
S  CM <£
i **/ v
O JC o  O>o 
£  co
CO CO
I c l ®  
S S T 3  
_§*55 "J«_J -w* 7\
89
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Campus-wide Email
Volunteering Opportunity at the University of Windsor
I am a Master of Human Kinetics student who is currently working on my 
research project which focuses on understanding the relationship between 
strength and mobility. We are inviting you to participate in this project. Currently, 
I require participants who have been diagnosed with Type 2 diabetes as well as 
individuals who do not have diabetes that are between 40 to 65 years of age. 
This project involves general health questionnaires, mobility/walking tests and 
strength assessment. This study has received approval from the University of 
Windsor Research Ethics Board. If you would like more information I (or my 
supervisor) would be happy to chat with you about the specifics of my Master’s 
project.
Thanks for your consideration,
Lynette A. Singh, BScH 
Master’s Candidate 
University of Windsor 
Faculty of Human Kinetics 
Department of Kinesiology 
Human Kinetics Bldg., Rm. 231 
Telephone: 519-253-3000 ext. 4049 
Email: singh3d@uwindsor.ca
Jennifer M. Jakobi, PhD 
University of Windsor 
Faculty of Human Kinetics 
Department of Kinesiology 
Human Kinetics Bldg., Rm. 120 
Telephone:519-253-3000 ext.2473 
Email: jjakobi@uwindsor.ca
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Appendix C. Questionnaires, Blood and Neuropathy Screening
Session One. Familiarization Session Checklist
Subject Code
Date
I | Consent Form (in file)
I I Letter of Information (to subject)
Q  Subject Contact Information (in confidential file)
I] Background Questionnaire (subject file)
I] Waterloo Footedness Questionnaire (subject file)
I] The Yale Physical Activity Survey for Adults (subject file)
0  SF-36 (subject file)
0  The Diabetes Self-Efficacy Scale (subject file)
3] The Activities-specific Balance and Confidence Scale (subject file)
I 1 The Berg Balance Scale (subject file)
I I The Timed “U p  and G O ” test (subject file)
0  The 4-metre timed walk (subject file)
1 I Step Test Exercise Prediction of V O 2 max (subject file)
I | The Michigan Neuropathy Screening Instrument Questionnaire (subject file) 
I | Neuropen Sensory Testing (subject file) 
l~1 HbAlc Test (subject file)
I | Schedule second session to the lab
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it
U H I  V 1 » » I  T T o r
WINDSOR
Day Two: Your Next Visit to the Neuromuscular Laboratory
Thank you very much for participating in the first part of the study. In order for 
us to complete this study, we ask that you come back to the laboratory for the 
second part (*) (**).
Your next visit is scheduled on:
*Please refrain from consuming any caffeine for at least 2 hours prior to this 
visit.
**Bring a pair of comfortable shorts and socks along with you.
Neuromuscular Laboratory 
Room 231
Human Kinetics Building
Please contact us if  you need to reschedule this visit.
Department of Kinesiology 
University of Windsor 
Windsor, Ontario N9B 3P4
Tel. 1 (519) 253-3000 e x t 4049
E-mail: singh3d@uwindsor.ca
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Session Two. Neuromuscular Assessment
Subject Code
Date
Non-Dominant Leg 
Tested
SG Excitation SG Sensitivity
taEMG Amplifier taEMG Gain High Pass Low Pass
lgEMG Amplifier lgEMG Gain High Pass Low Pass
A. Conduction Velocity and Supramaximal Twitch 
Q  10 single twitches to analyze
Max M -wave/Twitch Pulse Duration Current Voltage
Distance (mm) Stimulator electrode to Active sEhdG electrode:
File Name
B .M V C
□  1-3 x Practice MVC
□  3 x MVC to Analyze
File Name
C. F atigue
B lo o d  A n a ly s is  -  P A R T  O N E
Time Hours since last consumed food
Blood Lactate Before Blood Glucose Before
Blood Lactate After Blood Glucose After
Fused Tetanus Pulse Duration Current Voltage
1
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Fatigue Exercise plus 1 minute Recovery
File Name
F a tig u e  R ecovery  a fte r  3  m in u te s  R eco very
File Name
F a tig u e  R ecovery  a fte r  5 m in u te s  R eco very
File Name
F a tig u e  R ecovery  a fte r  JO m in u te s  R eco very
File Name
2
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Session One, Subject Contact Information
Name
Street Address
City
Province
Postal Code
Email
Phone Number
Emergency Contact
Emergency Contact Number
Subject Code
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Session One. Background Questionnaire
Subject Code
Section 1. Tell us about yourself.
Sex
Age
Date of Birth
Weight (kg)
Height (cm)
Girth Measurement (cm)
W :
Section 2. Tell us about your health
Are you a regular smoker? No
Yes
Do you consider yourself... At the Right Weight
Overweight
Underweight
Are you a frequent dieter? No
Yes
Have you had surgery in the past year? No
Yes
If so, type
Have you ever been diagnosed by a health 
professional as having any of the following? 
(Check all that apply, make specifications 
where applicable)
Heart trouble 
Arthritis
High Blood Pressure 
High Cholesterol 
Cardiac Pacemaker 
Electronic Implant 
Back problems 
Foot Problems 
Muscle Problems 
Bone or Joint Disorder 
Previous Injury 
Alcoholism
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Allergies (including hay fever and sinus problems)
Difficulties hearing 
Difficulties seeing 
Other health problems
Diabetes if YES, please complete 
Section 3
Family history of diabetes? No
Yes
If so, please provide details
Are you currently using any medications?
Section 3. Tell us about your diabetes
H o w  many years has it been since you were first 
diagnosed with Type 2 diabetes?
Do you receive regular medical care for your 
diabetes? (such as visits to a family physician, 
specialist etc.)
What level do you control your blood sugar?
What method(s) do you use to control Type 2 
diabetes? (please check all that apply, provide 
details if applicable)
Regular exercise
Weight loss
Special diet
Medications (please state which type(s) if 
possible)
Other
Have you received educational counselling with 
respect to controlling Type 2 diabetes?
Family physician
Diabetes educator 
Endocrinologist 
Dietician 
Other
Thank you for completing this background questionnaire. The information provided will assist in 
completion of this study. If you have found any of the sections unclear, please bring it to the
attention o f  the experimenter.
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Session One. Waterloo Footedness Questionnaire -  Revised
Instructions: Answer each of the following questions as best you can. If you always use one foot to perform the described activity, 
circle Ri or La (for right always or left always). If you usually use one foot circle Ru or Lu, as appropriate. If you use both feel 
equally often, circle Eq.
Please do not simply circle one answer for all questions, but imagine yourself performing each activity in turn, and then mark the 
appropriate answer. If necessary, stop and pantomime the activity.
1. Which foot would you use to kick a stationary ball at a target straight in front of you? La Lu Eq Ru Ra
2. If you had to stand on one foot, which foot would it be? La Lu Eq Ru Ra
3. Which fool would you use to smooth sand at the beach? La Lu Eq Ru Ra
4. If you had to step up onto a chair, which fool would you place on the chair first? La Lu Eq Ru Ra
5. Which foot would you use to stomp on a fast-moving bug? La Lu Eq Ru Ra
6. If you were lo balance on one foot on a railway track, which foot would you use? La Lu Eq Ru Ra
7. If you wanted to pick up a marble with your toes, which foot would you use? La Lu Eq Ru Ra
8. If you had to hop on one foot, which foot would you use? La Lu Eq Ru Ra
9. Which foot would you use to help push a shovel into the ground? La Lu Eq Ru Ra
10. During relaxed standing, people initially put most of their weight on one fool, leaving the 
other leg slightly bent. Which foot do you put most of your weight on first?
La Lu Eq Ru Ra
11. Is there any reason (i.e. injury) why you have changed your foot preference for any o f the 
above activities?
YES NO (circle one)
12. Have you ever been given special training or encouragement to use a particular foot for 
certain activities?
YES NO (circle one)
13. If you have answered YES for either question 11 or 12, please explain:
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Session One. The Yale Physical Activity Survey for Older Adults
INTERVIEWER: PLEASE MARK TIME: ____ :_____:_____
HR MIN SEC
INTERVIEWER: (Please hand the subject the list of activities while reading
this statement). Here is a list of common types of physical activities. 
Please tell me which of them you did during a typical week in the last month. 
Our interest is learning about the types of physical activities that are a 
part of your regular work and leisure routines.
For each activity you do, please tell me how much time (hours) you spent 
doing this activity during a typical week. (Hand subject card HI.)
Intensity
Work Time Code*
(Hrs/Wk) (kcal/min)
shopping (e.g., grocery, clothes)   3.5
Stair climbing while carrying a load    8.5
Laundry (time loading, unloading, hanging, folding only) ____  3-°
Light housework: tidying, dusting, sweeping; collecting
trash in home; polishing; indoor gardening; ironing ___  3.0
Heavy housework: vacuuming, mopping; scrubbing floors
and walls; moving furniture, boxes, or garbage cans ____ 4.5
Food preparation (10+ mins in duration): chopping
stirring; moving about to get food items, pans   2.5
Food service (10+ mins in duration): setting table;
carrying food; serving food   2.5
Dish washing (10+ mins in duration): clearing table;
washing/drying dishes, putting dishes away   2.5
Light home repair: small appliance repair;
light home maintenance/repair   3.0
Heavy home repair: painting, carpentry,
washing/polishing car   5.5
Other:         *
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Intensity 
Time code*
(Hrs/Wk) (keal/min)
Yardwork
Gardening: planting, weeding, digging, hoeing ____ 4.5
Lawn mowing (walking only)______________________________ ____ 4.5
Clearing walks/driveway: sweeping, shoveling, raking ____ 5.0
Other:  __________________________________________     +
Caretakina
Older or disabled person (lifting, pushing wheelchair) _______ 5.5
childcare (lifting, carrying, pushing stroller)   4.0
Exercise
Brisk walking (10+ mins in duration)    6.0
Pool exercises, stretching, yoga   3.0
Vigorous calisthenics, aerobics   6.0
Cycling, exercycle   6.0
Swimming (laps only)   6.0
Other:_________________________________________________    +
Recreational activities
Leisurely walking (10+ mins in duration)   3,5
Needlework: knitting, sewing, needlepoint, etc.   1.5
Dancing (mod/fast): line, ballroom, tap, square, etc. _______ 5.5
Bowling, bocci   3.0
Golf (walking to each hole only)   5.0
Racquet sports: tennis, racquet ball   7.0
Billiards   2.5
Other: _______ ______        +
100
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
INTERVIEWER: (please read to subject) . I would now like to ask you about
certain types of activities that you have done during the past month. I will 
ask you about how much vigorous activity, leisurely walking, sitting, 
standing, and some other things that you usually do.
1. About how many times during the month did you participate in vigorous 
activities that lasted at least 10 minutes and caused large increases in
breathing, heart rate, or leg fatique sc caused you to perspire? (Hand
subject card /2.)
SCORE: 0 = Not at all (go to Q3)
1 = 1-3 times per month
2 = 1-2 times per week
3 = 3 - 4  times per week 
4 = 5 +  times per week
7 = Refused
8 = Don't know FREQUENCY SCORE = ____________
2. About how long do you do this vigorous activity(ies) each time? (Hand 
subject card #3.)
s c o r e: o = Not applicable
1 = 10-30 minutes
2 = 31-60 minutes
3 = 60+ minutes
7 = Refused
8 = Don't know
DURATION SCORE =__ _____________
WEIGHT = 5
VIG0R0U8 ACTIVITY INDEX SCORE:
FREQ SCORE ___  X DUR SCORE   x WEIGHT   = _____________
(Responses of 7 or 8 are scored as missing.)
3. Think about the walks you have taken during the past month. About how 
many times per month did you walk for at least 10 minutes or more 
without stopping which was not strenuous enough to cause large increases 
in breathing, heart rate, or leg fatigue or cause you to perspire? (Hand 
subject card t2 .)
SCORE: 0 = Not at all (go to Q5)
1 = 1 - 3  times per month 
2 = 1 - 2  times per week 
3 - 3-4 times per week 
4 = 5 +  times per week
7 = Refused
8 = Don't know FREQUENCY SCORE = ____________
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4. when you did this walking, for how many minutes did you do it? (Hand 
subject card /3.)
SCORE;' 0 = Not applicable
1 = 10-30 minutes
2 = 31-60 minutes
3 = 60+ minutes
7 = Refused
8 = Don't know
DURATION SCORE = ______________
WEIGHT = 4
LEISURELY WALKING INDEX 8CORE:
FREQ SCORE   X DOR SCORE ___p X WEIGHT  __  = ______________
(Responses of 7 or 8 are scored as missing.)
5. About how many hours a day do you spend moving around on your feet while 
doing things? Please report only the time that you are actually moving. 
(Hand subject card #4.)
SCORE: 0 = Not at all
l = less than 1 hr per day
2 = 1  to less than 3 hrs per day
3 = 3 to less than 5 hrs per day
4 = 5 to less than 7 hrs per day
5 = 7 +  hrs per day
7 = Refused
8 = Don't know MOVING SCORE =  ;________
WEIGHT = 3
MOVING INDEX SCORE:
MOVING SCORE ______ X WEIGHT   =__ ______________
(Responses of 7 or 8 are scored as missing.)
6. Think about how much time you spend standing or moving around on your 
feet on an average day during the past month. About how many hours per 
day do you stand? (Hand subject card #4.)
SCORE: 0 » Not at all
1 = less than 1 hr per day
2 = 1 to less than 3 hrs per day
3 = 3 to less than 5 hrs per day
4 = 5 to less than 7 hrs per day
5 = 7 +  hrs per day
7 = Refused
8 = DK STANDING SCORE = ______________
WEIGHT = 2
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STANDING INDEX SCORE:
STANDING SCORE ______ X WEIGHT ___  =
(Responses of 7 or 8 are scored as missing.)
7. About how many hours did you spend sitting on an average day during the 
past month)(Hand subject card /5.)
score: o ■* Not at all
1 = less than 3 hours 
2 - 3  hours to less than 6 hours 
3 = 6 hours to less than 8 hours 
4 = 8 +  hours
7 » Refused
8 = Don't know SITTING SCORE = _______________
WEIGHT = 1
SITTING INDEX.SCORE:
SITTING SCORE _____ X WEIGHT ___ = _
(Responses of 7 or 8 are scored as missing.)
8. About how many flights of stairs do you climb up each day? (let 10 steps 
= 1 flight.)
Please compare the amount of physical activity that you do during other 
seasons of the year with the amount of activity you just reported for a 
typical week in the past month. For example, in the summer, do you do 
more or less activity than what you reported doing in the past month?
(INTERVIEWER: PLEASE CIRCLE THE APPROPRIATE SCORE FOR EACH SEASON.)
Lot Little Little Lot
Mere More Same Less Less
Spring 1.30 1.15 1.00 0.85 0.70
Summer 1.30 1.15 1.00 0.85 0.70
Fall 1.30 1.15 1.00 0.85 0.70
Winter 1.30 1.15 1.00 0.85 0.70
Don't know
SEASONAL ADJUSTMENT SCORE = SUM OVER ALL SEASONS / 4
INTt'KVJLEWEk PLEASE MARK TIME:    :______
HR SEC MIN
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CARD #1
WEEKLY PHYSICAL ACTIVITIES
Work
Shopping (e.g., grocery, clothes) 
stair climbing while carrying a load 
Laundry
Light Housework:
Heavy Housework:
Food preparation (10+ min.):
Food service (10+ min.):
Dish washing (10+ min.):
Light home repair:
Heavy home repair:
Other:
Yardwork
Gardening:
Lawn mowing (walking only)
Clearing walks and driveway:
Other:
104
tidying, dusting, sweeping, 
collecting garbage in home, 
polishing, indoor gardening, 
ironing
vacuuming, mopping, scrubbing 
floors and walls, moving 
furniture, moving boxes or 
garbage cans
chopping, stirring, moving 
around to get food items, pots 
or pans
setting table, carrying food, 
serving food
clearing table, washing and 
drying dishes, putting dishes 
away
small appliance repair, light 
household maintenance and 
repair tasks
painting, washing and 
polishing car, carpentry
pruning, planting, weeding, 
hoeing, digging
raking, shoveling, sweeping
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Caretaklncr
Older or disabled person:
Childcare:
Exercise
Brisk walking for exercise (10+ min.):
Stretching exercises, yoga, pool 
exercise
Vigorous calisthenics, aerobics:
Cycling, exercycle 
Lap swimming 
other:
Recreational Activities
Leisurely walking (10+ min.)
Hiking
Needlework:
Dancing (mod/fast):
Bowling, boccie
Golf (walking to each hole only) 
Racquet sports:
Billiards
Other:
lifting, pushing wheelchair 
lifting, pushing stroller
causes large increases in 
heart rate, breathing or leg 
fatigue
causes large increases in 
heart rate, breathing or leg 
fatigue
knitting, sewing, crocheting, 
needlepoint
line dancing, ballroom, 
square, tap, etc.
tennis, racquetball
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CARD #2
Not at a ll 
1-3 times per month 
1-2 times per week 
3-4 times per week 
5 or more times per week 
Don't know
CARD #3
10-30 minutes 
31-60 minutes 
60 or more minutes 
Don't know
CARD #4 
Not at a ll
less than 1 hour per day
1 to less than 3 hours per day
3 to less than 5 hours per day
5 to less than 7 hours per day
7 or more hours per day 
Don't know
CARD /5 
Not at a ll
less than 3 hours per day 
3 hours to less than 6 hours per day 
6 hours to less than 8 hours per day 
8 or more hours per day 
Don't know
106
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Session One. Medical Outcomes Study: 36-Item Short Form Survey Instrument
RAND 36-Item  Health Survey 1.0 Questionnaire Item s
;; 1. In general, would you say your health Is:
Excellent 1
Very good 2
; Good 3
Fair 4
Poor 5
: 2. Compared to one year ago, how would your rate your health in general now?
Much better now than one year ago 1
i Somewhat better now than one year ago 2
About the same 3
Somewhat worse now than one year ago 4
Much worse now than one year ago 5 .
The following items are about activities you might do during a typical day. Does your health now lim it you in these activities? If 
so, how much?
(Circle One Number on Each Line)
Yes, Limited a 
Lot
Yes, Limited a 
Little
No, Not limited 
at All
3. Vigorous activities, such as running, lifting heavy objects, 
participating in strenuous sports
i n [2 ] [3]
4. Moderate activities, such as moving a table, pushing a vacuum 
cleaner, bowling, or playing golf
i n [2 ] [3]
5. Lifting or carrying groceries [ i ] [2] [3]
6. Climbing several flights of stairs H i [2] [3]
7. Climbing one flight of stairs
I 1! [2] [3]
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8, Bending, kneeling, or stooping [1 ] [2 ] [3 ]
9. Walking more than a mile [1 ] [2 ] [3 ]
10. Walking several blocks [1 ] [2 ] [3 ]
11. Walking one block [1 ] [2 ] [3]
12. Bathing or dressing yourself [1 ] [2 ] [3]
During the past 4 weeks, have you had any o f the following problems with your work or other regular daily activities as a result 
of your physical health?
(Circle One Number on Each Line)
Yes No
13. Cut down the amount of time you spent on work or other activities 1 2
14. Accomplished less than you would like 1 2
15. Were limited In the kind of work or o ther activities 1 2
16. Had difficulty performing the work or other activities (for example, it took extra effort) 1 2
During the past 4  weeks, have you had any of the following problems with your work or other regular daily activities as a result 
of any emotional problems (such as feeling depressed or anxious)?
(Circle One Number on Each Line)
Yes No
17. Cut down the am ount of tim e you spent on work or other activities 1 2
18. Accomplished less than you would like 1 2
19. Didn't do work or other activities as carefully as usual 1 2
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20. During the past 4  weeks, to what extent has your physical health or emotional problems interfered with your normal social 
activities with family, friends, neighbors, or groups?
(Circle One Number)
Not at all 1 
Slightly 2 
Moderately 3 
Quite a bit 4 
Extremely 5
21. How much bodily pain have you had during the past 4 weeks?
(Circle One Number)
None 1 
Very mild 2 
Mild 3 
Moderate 4 
Severe 5 
Very severe 6
22. During the past 4  weeks, how much did pain interfere with your normal work (including both work outside the home and 
housework)?
(Circle One Number)
Not at all 1 
A little bit 2 
Moderately 3 
Quite a bit 4 
Extremely 5
These questions are about how you feel and how things have been with you during the past 4 weeks. For each question, please 
give the one answer that comes closest to the way you have been feeling.
How much of the time during the past 4 weeks . . .
(Circle One Number on Each Line)
All of the 
Time
Most of 
the Time
A Good Bit 
of the Time
Some of 
the Time
A Little of 
the Time
None of 
the Time
23. Did you feel full of pep? 1 2 3 4 5 6
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24. Have you been a very nervous 
person?
1 2 3 4 5 6
25. Have you felt so down in the 
dumps that nothing could cheer you 
up?
1 2 3 4 5 6
26. Have you felt calm and peaceful? 1 2 3 4 5 6
27. Did you have a lot of energy? 1 2 3 4 5 6
28. Have you felt downhearted and 
blue?
1 2 3 4 5 6
29. Did you feel worn out? 1 2 3 4 5 6
30. Have you been a happy person? 1 2 3 4 5 6
31. Did you feel tired? 1 2 3 4 '  5 6
32. During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your 
social activities (like visiting with friends, relatives, etc,)?
(Circle One Number)
All of the time 1 
Most of the time 2 
Some of the time 3 
A little of the time 4 
None of the time 5
How TRUE or FALSE is each of the following statements for you. (Circle One Number on Each Line)
Definitely
True
Mostly
True
Don't
Know
Mostly
False
Definitely
False
33. I seem to get sick a little easier than other 
people
1 2 3 4 5
34. I am as healthy as anybody I know 1 2 3 4 5
35. I expect my health to get worse 1 2 3 4 5
36. My health is excellent 1 2 3 4 5
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Session One. The Diabetes Self-Efficacy Scale (DSES)
We would like to know how confident you are in doing certain activities. For each of the following 
questions, please choose the number that corresponds to your confidence that you can do the tasks 
regularly at the present time.
1. How confident do you feel that you 
can eat your meals every 4 to 5 
hours every day, including breakfast 
every day?
2. How confident do you feel that you 
can follow your diet when you have 
to prepare or share food with other 
people who do not have diabetes?
3. How confident do you feel that you 
can choose the appropriate foods to 
eat when you are hungry (for 
example, snacks)?
4. How confident do you feel that you 
can exercise 15 to 30 minutes, 4 to 5 
times a week?
5. How confident do you feel that you 
can do something to prevent your 
blood sugar level from dropping 
when you exercise?
6. How confident do you feel that you 
know what to do when your blood 
sugar level goes higher or lower than 
it should be?
not at all | | | | | | | | | | totally
confident 1 2 3 4 5 6 7 8 9 1 0  confident
not at all | | | | | | | | | | totally
confident 1 2 3 4 5 6 7 8 9 1 0  confident
not at all | | | | | | | [ | | totally
confident 1 2 3 4 5 6 7  8 9 1 0  confident
not at all | | | | | | | | | | totally
confident 1 2 3 4 5 6 7  8 9 1 0  confident
not at all | | | | | | | | | | totally
confident 1 2 3 4 5 6 7 8 9 1 0  confident
not at all | | | | | | | | | | totally
confident 1 2 3 4 5 6 7 8 9 1 0  confident
7. How confident do you feel that you 
can judge when the changes in your 
illness mean you should visit the 
doctor?
not at all | | | | | | | | | | totally
confident 1 2 3 4 5 6 7  8 9 1 0  confident
8. How confident do you feel that you 
can control your diabetes so that it 
does not interfere with the things you 
want to do?
not at all | | | | | | | | | | totally
confident 1 2 3 4 5 6 7  8 9 1 0  confident
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Session One. The Activities-specific Balance and Confidence scale (ABC scale) (Powell &  Myers 
1995)
' For each of the following activities, please indicate your level of self-confidence by choosing a 
corresponding number from the following rating scale:
0% 10 20 30 40 50 60 70 80 90 1 0 0 %
No confidence Completely confident
How confident are you that you can maintain your balance and remain steady when you . . ,
1. walk around the house? _____ %
2. walk up or down stairs? ____ _%
3. bend over and pick up a slipper from the front of a closet floor? _____ %
4. reach for a small can off a shelf at eye level? _____ %
5. stand on your tip toes and reach for something above your head? _____ %
6. stand on a chair and reach for something? _____ %
7. sweep the floor? _____ %
8. walk outside the house to a car parked in the driveway? _____ %
9. get into or out of a car? _____ %
10. walk across a parking lot to the mall? _____ %
11. walk up or down a ramp?  ____ %
12. walk in a crowded mall where people rapidly walk past you? _____ %
13. are bumped into by people as you walk through the mall? ._____%
14. step on or off an escalator while holding onto a railing? _____ %
15. step on or off an escalator while holding parcels and cannot hold onto the railing? -------%
16. walk outside on icy sidewalks? _____ %
Note. From Powell and Myers (1995), Myers et al. (1996), and Myers et al. (1998). Reprinted 
with permission of the Gerontology Society of America. Copyright by the GSA.
Administrating the ABC
The ABC can be self-administered or administered via personal or telephone interview. Use a 
larger typeset font for self-administration, while an enlarged version of the rating scale on an 
index card w ill facilitate in-person interviews. Instruct respondents, 'I f  you do not currently 
do the activity in question, try to imagine how confident you would be if you had to do the 
activity. If you normally use a walking aid or hold onto someone, rate your confidence qs if you 
were using these supports. If you have any questions, please ask.'
Instruetionsfor-Scoring
Total the ratings (possible range = 0 to 1,600) and divide by 16 (or the number of items 
completed) to get each person's ABC score. If a person qualifies her response to items 2, 9, 11, 
14, or 15, solicit separate ratings and use the low est confidence of the two (as this will limit the 
entire activity, e.g., likelihood of using stairs). Total scores can be computed if at least 12 of the 
16 items are answered and alpha does not decrease appreciably with the deletion of item 16 
icy sidewalks—for administration in warmer climates (Myers et ol. T998)._________________
The ABC has good test-retest reliability, high internal consistency, is able to discriminate between 
fallers and nonfallers and low versus high mobility groups (Powell and Myers 1995), and 
corresponds with balance performance measures (Myers el ol. 1996). ABC scores above 50 and 
less than 80 are indicative of a moderate level of functioning characteristic of persons with 
chronic health conditions. Scores above 80 indicate higher functioning, usually active older 
adults and are achievable through exercise and rehabilitative therapies (Myers et al. 1998).
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D a y  1. B lood A nalysis C hecklist: H b A lc  testing
Subject Code
Date
□  Put gloves on
□  Warm hand to increase blood flow
□  Clean skin with alcohol wipe
□  Prepare lancing device
□  Set up HbAlc holder and chemical, open cap
□  Lance skin
□  Express blood drop and wipe with cotton pad
□  Express blood drop into capillary for HbAlc
□  Fill HbAlc capillary tube to black line (do not squeeze)
□  Squeeze blood into HbAlc chemical tube and squeeze rinse 2-3 times
□  Recap tube and shake vigorously 6-8 times
□  Wipe finger and apply dressing if needed
□  Open Pouch 2 of HbAlc, insert cartridge into metre immediately, monitor/code match
□  ♦ S M P L  appears, fill dropper by squeezing and releasing slowly (leave dropper in tube)
□  Liquid in overflow bubble (never out) squeeze capillary contents only xl onto test spot
□  Results in 5 minutes, alternating signal Q C O K  unless error code
Glycosylated Hemoglobin Level (%)
□  Remove cartridge from HbAlc metre and dispose, remove gloves and dispose
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Session One. The Michigan Neuropathy Screening Instrument Questionnaire (MNSI)
Please take a few minutes to answer the questions below about the feeling in your legs and feet. 
Circle YES or NO based on how you usually feel.
1. Are your legs and/or feet numb? Y E S  N O
2. Do you ever have any burning pain in your legs and/or your Y E S  N O
feet?
3. Are your feet too sensitive to touch? Y E S  N O
4. Do you get muscle cramps in your legs and/or feet? Y E S  N O
5. Do you ever have any prickling feelings in your legs or feet? Y E S  N O
6. Does it hurt when the bed covers touch your skin? Y E S  N O
7. When you get into the tub or shower, are you able to tell the Y E S  N O
hot water from the cold water?
8. Have you ever had an open sore on your foot? Y E S  N O
9. Has your doctor ever told you that you have diabetic Y E S  N O
neuropathy?
10. Do you feel weak all over most of the time? Y E S  N O
11. Are your symptoms worse at night? Y E S  N O
12. Do your legs hurt when you walk? Y E S  N O
13. Are you able to sense your feet when you walk? Y E S  N O
14. Is the skin on your feet so dry that it cracks open? Y E S  N O
15. Have you ever had an amputation? Y E S  N O
Scoring: The greater the number of positive (yes) responses equals the greater the severity of 
neuropathy. Tabulate score out of 15, each “yes” response receives one point and “no” receives zero 
points (Feldman et al., 1994).
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Session One. Screening for Peripheral Neuropathy -  Checklist (per Neuropen Instructions)
Subject Code
o Rest subject’s foot on a stable and padded surface (towel on floor). Ensure they are 
comfortable and free from distractions 
o Wipe the tip with an alcohol pad in the presence of the subject
o Explain testing procedure by showing them how stimulus feels on the back of their hand 
o Once testing begins, ensure the patient cannot see the test being performed, use a shield or 
ask them to look away
o Press the monofilament at 90° angle to the skin surface and increase pressure until it bows - 
hold it for 2 seconds. Instruct the subject to say “yes” or “now” when they believe that they 
can detect the stimulus. Test sites at random on dorsum of great toe on the non-dominant leg. 
Place an x where site of compression is detected. Put an “N ” where no stimulus is sensed. 
Repeat test a total of 10 times, 
o Wipe tip of pen with alcohol after end of test. Replace a tip and discard in sharps container 
after ten trials (100 uses). D O  N O T  U S E  N E A R  B R O K E N  SKIN/OPEN SORES. IF THIS 
C A N N O T  B E  AVOIDED, U S E  A  N E W  TIP A N D  D I S C A R D  A F T E R  U S E  IN SHARPS 
CONTAINER.
LEFT RIGHT
p
P l \
S C O R E  _____ /10
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Appendix D. Balance, Functional Mobility and Performance Scoring
Session One, Berg Balance Scale (BBS)
ITEM D E S C R I P T I O N  S C O R E  (0-4)
1. Sitting to standing_______________________ _____
2. Standing unsupported _____
3. Sitting unsupported _____
4 Standing to sitting _____
5. Transfers _____
6. Standing with eyes closed _____
7. Standing with feet together _____
8. Reaching forward with outstretched arm _____
9. Retrieving object from floor _____
10. Turning to look behind___________________ _____
11. Turning 360 degrees_____________________ _____
12. Placing alternate foot on stool__________________
13. Standing with one foot in front ______
14. Standing on one foot_____________________ _____
TOTAL _____
* references on page 4
GENERAL INSTRUCTIONS
Please demonstrate each task and/or give instructions as written. Wh e n  scoring, please record 
the lowest response category that applies for each item.
In most items, the subject is asked to maintain a given position for specific time. Progressively 
more points are deducted if the time or distance requirements are not met, if the subject's 
performance warrants supervision, or if the subject touches an external support or receives 
assistance from the examiner. Subjects should Understand that they must maintain their balance 
while attempting the tasks. The choices of which leg to stand on or how far to reach are left to 
the subject. Poor judgment will adversely influence the performance and the scoring.
Equipment required for testing are a stopwatch or watch with a second hand, and a ruler or other 
indicator of 2, 5 and 10 inches (5, 12.5 and 25 cm). Chairs used during testing should be of 
reasonable height. Either a step or a stool (of average step height) may be used for item # 12.
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SITTING TO STANDING
INSTRUCTIONS: Please stand up. Try not to use your hands for support.
( ) 4 able to stand without using hands and stabilize independently
( ) 3 able to stand independently using hands
( ) 2 able to stand using hands after several tries
( ) I needs minimal aid to stand or to stabilize
( ) 0 needs moderate or maximal assist to stand
2 . STANDING UNSUPPORTED
INSTRUCTIONS: Please stand for two minutes without holding.
( ) 4 able to stand safely 2 minutes
( ) 3 able to stand 2 minutes with supervision
( ) 2 able to stand 30 seconds unsupported
( ) I needs several tries to stand 30 seconds unsupported
( ) 0 unable to stand 30 seconds unassisted
I f  a subject is able to stand 2 minutes unsupported, score fu ll points fo r sitting unsupported. Proceed to item #4.
3. SITTING WITH BACK UNSUPPORTED BUT FEET SUPPORTED ON FLOOR OR ON A 
STOOL
INSTRUCTIONS: Please sit with arms folded for 2 minutes.
( )4 able to sit safely and securely 2 minutes
( )3 able to sit 2 minutes under supervision
( >2 able to sit 30 seconds
( )1 able to sit 10 seconds
( )0 unable to sit without support 10 seconds
4. STANDING TO SITTING
INSTRUCTIONS: Please sit down.
( ) 4 sits safely with minimal use of hands
( ) 3 controls descent by using hands
( ) 2 uses back of legs against chair to control descent
( ) 1 sits independently but has uncontrolled descent
( ) 0 needs assistance to sit
5. TRANSFERS
INSTRUCTIONS: Arrange chairs(s) for a pivot transfer. Ask subject to transfer one way toward a seat 
with armrests and one way toward a seat without armrests. You may use two chairs (one with and one 
without armrests) or a bed and a Chair.
( ) 4  able to transfer safely with minor use of hands
( )3 able to transfer safely definite need of hands
( ) 2 able to transfer with verbal cueing and/or supervision
( ) 1 needs one person to assist
( ) 0 needs two people to assist or supervise to be safe
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6 STANDING UNSUPPORTED WITH EYES CLOSED
INSTRUCTIONS: Please close your eyes and stand still for 10 seconds.
( )4 able to stand 10 seconds safely
( )3 able to stand 10 seconds with supervision
( ) 2 able to stand 3 seconds
( ) 1 unable to keep eyes closed 3 seconds but stays steady
( ) 0 needs help to keep from falling
7. STANDING UNSUPPORTED WITH FEET TOGETHER
INSTRUCTIONS: Place your feet together and stand without holding.
( ) 4 able to place feet together independently and stand 1 minute safely
( ) 3 able to place feet together independently and stand for 1 minute with supervision
( ) 2 able to place feet together independently and to hold for 30 seconds
( ) 1 needs help to attain position but able to stand 15 seconds feet together
( ) 0 needs help to attain position and unable to hold for 15 seconds
8 REACHING FORWARD WITH OUTSTRETCHED ARM WHILE STANDING 
INSTRUCTIONS: Lift arm to 90 degrees. Stretch out your fingers and reach forward as far as you 
can. (Examiner places a ruler at end of fingertips when arm is at 90 degrees. Fingers should not touch 
the ruler while reaching forward. The recorded measure is the distance forward that the finger reach 
while the subject is in the most forward lean position. When possible, ask subject to use both arms 
when reaching to avoid rotation of the trunk.)
( ) 4 can reach forward confidently >25 cm (10 inches)
( ) 3 can reach forward >12.5 cm safely (5 inches)
( ) 2 can reach forward >5 cm safely (2 inches)
( ) 1 reaches forward but needs supervision
( ) 0 loses balance while trying/ requires external support
9 PICK UP OBJECT FROM THE FLOOR FROM A STANDING POSITION
INSTRUCTIONS: Pick up the shoe/slipper which is placed in front of your feet.
( ) 4 able to pick up slipper safely and easily
( )3 able to pick up slipper but needs supervision
( ) 2 unable to pick up but reaches 2-5cm (1-2 inches) from slipper and keeps balance independently
( ) 1 unable to pick up and needs supervision while trying
( ) 0 unable to try/needs assist to keep from losing balance or falling
10. TURNING TO LOOK BEHIND OVER LEFT AND RIGHT SHOULDERS WHILE STANDING 
INSTRUCTIONS: Turn to look directly behind you over toward left shoulder. Repeat to the right. 
Examiner may pick an object to look at directly behind the subject to encourage a better twist turn.
( ) 4 looks behind from both sides and weight shifts well
( ) 3 looks behind one side only other side shows less weight shift
( ) 2 turns sideways only but maintains balance 
( ) 1 needs supervision when turning
( ) 0 needs assist to keep from losing balance or falling
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11. TURN 360 DEGREES
INSTRUCTIONS: Turn completely around in a full circle. Pause. Then turn a full circle in the other 
direction.
( ) 4 able to turn 360 degrees safely in 4 seconds or less
( ) 3 able to turn 360 degrees safely one side only in 4 seconds or less
( ) 2 able to turn 360 degrees safely but slowly 
( ) 1 needs close supervision or verbal cueing 
( ) 0 needs assistance while turning
12. PLACING ALTERNATE FOOT ON STEP OR STOOL WHILE STANDING UNSUPPORTED
INSTRUCTIONS: Place each foot alternately on the step/stool. Continue until each foot has touched 
the step/stool four times.
( ) 4 able to stand independently and safely and complete 8 steps in 20 seconds
( ) 3 able to stand independently and complete 8 steps >20 seconds
( ) 2 able to complete 4 steps without aid with supervision
( ) 1 able to complete >2 steps needs minimal assist
( )0  needs assistance to keep from falling/unable to try
13. STANDING UNSUPPORTED ONE FOOT IN FRONT
INSTRUCTIONS: (DEMONSTRATE TO SUBJECT)
Place one foot directly in front o f the other. If you feel that you cannot place your foot directly in front, try 
to step far enough ahead that the heel o f your forward foot is ahead of the toes of the other foot. (To score 3 points, 
the length of the step should exceed the length of the other foot and the width of the stance should approximate the 
subject's normal stride width)
( ) 4 able to place foot tandem independently and hold 30 seconds 
( ) 3 able to place foot ahead o f other independently and hold 30 seconds
( ) 2 able to take small step independently and hold 30 seconds
( ) 1 needs help to step but can hold 15 seconds 
( ) 0 loses balance while stepping or standing
14. STANDING ON ONE LEG
INSTRUCTIONS: Stand on one leg as long as you can without holding.
( )4  able to lift leg independently and hold >10 seconds
( )3 able to lift leg independently and hold 5-10 seconds
( ) 2 able to lift leg independently and hold = or >3 seconds
( ) 1 tries to lift leg unable to hold 3 seconds but remains standing independently
( ) 0 unable to try or needs assist to prevent fall
( ) TOTAL SCORE (Maximum = 56)
119
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Session One. Physical Performance Score Sheets
Subject Code
1. Timed “up and go’* test (TUG)
The T U G  test involves measurement of the time (seconds) that it takes for a person to stand 
up from an arm chair (approximately 45 cm  high) after “go”, walk a straight distance of 3 m  at a 
comfortable or regular pace, turn, walk back to the chair and sit down again (Figure 3).
Practice Trial (not timed)
Time to complete task s
* Regular footwear is worn, using any ambulatory aids that s/he normally uses, without any other 
sort of physical assistance. The person begins the test with her/his back against the chair with any 
ambulatory aids available in hand. A  fust try is given in order to familiarize the subject with the 
protocol (Podsiadlo &  Richardson, 1991).
< *
►
PIVOT
Time (s) to get up, walk to pivot point, pivot, walk back to chair and sit down
3 metres between chair and pivot point, one-way
X
120
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Subject Code
2. The 4-metre timed walk.
The subject will be asked to walk in a 4 m  pathway. At the start, each subject will be required 
to stand with both feet touching the start line, and commence walking at a normal, comfortable speed 
at the instruction “go”. The time it takes for the individual to walk 1 m  from the start and 4 m  from 
start will be recorded (Figure 6). This protocol will be repeated 3 times (2 times per usual pace and 1 
time at the fastest walking pace). The speed of the faster usual pace walks will be recorded. To 
calculate average walking speed, 4 m  or lm divided by time to complete the task (seconds). Regular 
footwear is worn, using any walking aids that s/he normally uses, without any other sort of physical 
assistance (Guralnik et al., 1995).
Usual Pace:
Time to walk l m _________________________ s
Time to walk 4 m  ____________  s
Usual Pace:
Time to walk lm  _______________ s
Time to walk 4 m    s
Fastest Pace:
Time to walk l m _________________________ s
Time to walk 4 m _________________________ s
Walking Speed_______________________ m/s
Walking Speed_______________________ m/s
Walking Speed_______________________ m/s
Walking Speed  ___________ m/s
Walking Speed_______________________ m/s
Walking Speed_______________________ m/s
1 metre 3 metres 3
Time (s) to complete 1 m o f  task
Total time (s) to complete task
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Subject Code
3. Step Test Exercise Prediction o f  VO* max (STEP)
Two 20 cm steps will be used for stepping up (both feet on top of step) and down (both feet at 
bottom of step) 20 times at three difference paces (Figure 5), Resting heart rate will be measured 
before die onset of the tests. In the first part (familiarization component), the subject will be asked to 
step up and down 10 step cycles at a pace considered by the subject to be “slow”. After 5 minutes of 
rest, the subject will be asked to repeat the step protocol, but using 20 step cycles instead of 10 step 
cycles at a “normal” pace (timed in seconds) and post-exercise heart rate will also be recorded 
immediately as well as their R P E  (Table 2). After another 5 minute rest period or after the heart rate 
returns to within 5 beats per minute (BPM) of the resting heart rate, file subject will be asked to 
repeat the procedure (20 steps cycles) but at a “fast” pace (timed in seconds) and post-exercise heart 
rate will also be recorded (Table 2). Step test speed, heart rate reserve, oxygen cost of stepping and 
oxygen pulse will be calculated (Table 3) andVOj max will be estimated for males and females 
(Table 4) (Petrella et al., 2001).
Resting Heart Rate _____    B P M
Step Task Rate Time to Complete Task (s) Post-Exercise Heart Rate (BPM) R P E
Normal T1 SHRi 6-20
bast T2 s h r 2 6-20
Step Task Rate Time to Complete Task (s) Post-Exercise Heart Rate (BPM) R P E
Normal
Fast
2& cm
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OBJECTIVE -
Assess the role of muscle strength on functional mobility when physical activity is matched 
in addition to weight, gender, and age in persons with type 2  diabetes.
METHOD -
Physical activity was assessed and (N=14) matched between persons with type 2 diabetes 
and non-diabetic controls. Performance tests were conducted and isometric muscle 
properties and strength measured.
RESULTS -
Physical activity was similar (p=0.83) but HbAlc was significantly elevated in the type 2 
diabetes group (8.4 + 1.3 %) compared with controls (6.1 + 0.4 %). Contractile properties 
(p=0.66) and strength were similar between groups (p=0.19). When gender and physical 
activity were considered independent factors vigorous activity accounted for 25 % of muscle 
strength and functional mobility scores were no lower in persons with type 2  diabetes. 
CONCLUSION -
Hyperglycaemia does not cause muscle weakness and subsequent declines in function in 
persons with type 2 diabetes. Daily activity may maintain muscle strength, but exercise is 
needed to lower hyperglycaemia and preserve mobility.
KEYWORDS -
Physical activity, exercise, functional mobility, strength, gender
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In tro d u c tio n  -
Deterioration of functional mobility is estimated to be 2 to 3 times higher in persons with 
diabetes compared to individuals without (1-3), and this decline is exacerbated in women 
(4). The association between muscle weakness and decline of functional mobility in 
persons with type 2  diabetes is questionable because most studies do not quantify muscle 
strength; rather manual muscle testing or subjective questionnaire assessments have been 
utilized. In addition, there is substantial literature to suggest that women are generally 
weaker than men (5) and that exercise training increases muscle strength resulting in 
higher functional mobility scores (6 ), but this knowledge is generally not applied to studies 
of persons with type 2 diabetes. In order to clearly ascertain whether muscle weakness 
influences functional mobility in persons with type 2  diabetes, gender and physical activity 
(PA) must be considered independent factors, and strength quantified in individuals without 
co-morbidities associated with hyperglycaemia. Co-morbidities such as neuropathies, foot 
ulcerations, retinopathy and nephropathy are also autonomous factors that influence 
muscle strength and thus these conditions should be excluded from independent 
assessment of PA on strength and muscle function. In this study we have weight-, age-, 
gender- and activity-matched persons with type 2  diabetes to non-diabetic control subjects 
to determine whether muscle strength is altered with chronic hyperglycaemia in a manner 
that impairs functional mobility.
M ethods -
Subjects, Diabetes and Physical Activity Assessments
Prior to participation all subjects provided written informed consent. Persons with type 2 
diabetes were recruited from the local university area; all were independent community 
dwelling adults. A local diabetes education group, posters (-75), community newspaper
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(distribution rate; 207,163), and mass campus email to staff and faculty (2,339 distribution 
list) were utilized for subject recruitment. The majority of respondents (n=20) were from the 
campus email advertisements, whereas the fewest responses came through diabetes 
educators (n=1). Control subjects were recruited similarly and matched with extreme care 
to persons with diabetes (Table 1). Initially subjects were screened with the self-report 
Yale Physical Activity Survey (7) and excluded based upon contraindications of the study 
(physician diagnosed diabetic neuropathies, bone spurs, fibromyalgia, cardiac 
complications). Consequent to a possible match objective physical performance tests were 
conducted. The sample consisted of 14 persons with type 2  diabetes (n= 6  $, n= 8  S) where 
1 0  (n= 6  $, n=4 S) were successfully matched to control subjects. Three male persons with 
type 2 diabetes were unmatched because of high weight or low activity scores (128.9 ± 8.3 
kg, 3-4x less) and the fourth male subject was excluded due to extensive participation in 
planned exercise training (3x higher than other scores).
The RAND 36-item Health Survey 1.0 [SF-36] was utilized to assess physical functioning, 
bodily pain, role limitations from health problems, and role limitations from emotional or 
personal issues, emotional well-being, social functioning, energy/fatigue and perception of 
general health. The Diabetes Self-Efficacy Scale [DSES] was employed to yield information 
about personal confidence with respect to living and caring for diabetes (8 ). The Activities- 
specific Balance and Confidence scale [ABC] (9) assessed balance confidence performing 
daily activities. A series of physical performance tests were utilized to quantify functional 
mobility and balance, including the Berg Balance Scale [BBS] (10), and the Timed “up and 
go” test [TUG] (11). The Step Test Exercise Prediction (STEP) was employed to measure 
heart rate responses to exercise, and to estimate submaximal oxygen uptake (1 2 ).
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Sensory threshold was assessed using a 10- Semmes-Weinstein monofilament (Neuropen, 
Owen Mumford Ltd., UK) by application of the filament to the dorsum of each great toe (13). 
In conjunction with this test the Michigan Neuropathy Screening Instrument [MNSI] was 
also utilized to assess the existence of peripheral neuropathy (14). Control subjects were 
also tested to maintain consistency between groups and to assess non-diabetic related 
sensory abnormalities.
Muscle Properties
Voluntary strength and electrically induced contractile properties were assessed in the 
tibialis anterior. This muscle is the primary dorsi-flexor (raising forefoot and toes) and is 
closely associated with deterioration of gait (15). All tests were performed on the non­
dominant leg except in three instances where knee joint surgery (n=2 ) or previous muscle 
injury (n=1) precluded investigation. The subject was seated in a custom-built isometric 
dynamometer with the ankle at 30° of plantar flexion, and the hip and knee joints positioned 
at 90°. The commercial load cell was fixed to the underside of the metal footplate (Model 
MLP-500-T, Transducer Techniques, Inc., Temecula, CA). Signals from the load cell were 
amplified (1000x) filtered (60-Hz notch filter), and sampled at 1000 Hz (Model V72-25A, 
Coulbourn Instruments, Allentown, PA) and subsequently analog to digital converted with 
offline quantification (Spike 2, Cambridge Electronic Design Ltd., Cambridge, UK).
Contractile properties w ere elicited percutaneously using an electrical stimulator (DS7AH, 
Digitimer Ltd., Hertfordshire, UK) and a hand-held custom-made electrode bar (4 cm 
length). The peroneal nerve was palpated along the lateral side of the patello-femoral joint. 
Pulse intensity was determined by slow increases in current until a plateau in twitch force
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was obtained. Ten maximal electrical pulses (100ps) at a frequency of 1 Hz were applied 
and the peak torque (PT), time to peak torque (TPT) and half relaxation time (HRT) 
determined from an average of 8-10 responses. To assess maximal voluntary contraction 
(MVC) subjects were instructed to lift their forefoot upward as hard and as fast as possible 
and maintain the position for 5 seconds while provided with visual feedback from an 
oscilloscope and strong verbal encouragement. To familiarize subjects with the MVC 3-5 
practise attempts were given prior to testing. Following the practice trials 3 ‘test’ 
contractions were performed and the highest attempt was utilized in the analysis. In order 
to verify that the force produced was maximal the twitch interpolation technique was utilized 
which involves application of a maximal electrical stimulus over the peroneal nerve during 
and after the MVC. The presence of a superimposed twitch on the force record indicates a 
lack of motivation or central failure. This measure is quantified by expressing the difference 
in amplitude of the interpolated twitch response to the post MVC twitch response as a 
percentage of the latter (16,17).
A two-way analysis of variance (gender x diabetic condition) was utilized to determine 
differences in muscle strength, PA, health and well-being between persons with type 2 
diabetes and controls. All values are reported as the mean + standard deviation. 
Significance set at p < 0.05.
Results -
Subjects, Diabetes and Physical Activity Assessments
Physical activity was successfully matched between the two groups with the questionnaire, 
but glucose at the time of testing and HbAlc were significantly greater in persons with type 
2 diabetes (Table 1). The average duration of physician diagnosed diabetes was 5.2 ± 4.4
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years. As the primary means to manage hyperglycaemia 7 subjects were utilizing oral 
hypoglycaemic agents, two insulin and one diet manipulations. All persons with diabetes 
indicated that they were aware of the benefits of exercise in managing diabetes, but all 
subjects reported that they did little exercise and all considered themselves overweight.
The neuropathy scores, as assessed with the MNSI and monofilament scores did not differ 
between groups (Table 2). Results from the RAND SF-36 questionnaire indicated that 
persons with type 2  diabetes perceived their health to be worse compared to the non­
diabetic control group, specifically how poor emotional and physical health (p=0.004 -
0.02) had affected their social life (family, work, friends) (Figure 1). This is the first study to 
measure muscle properties and match PA between groups, and when activity is accounted 
for functional performance measures did not differ for fear of falling (ABC), balance (BBS), 
mobility (TUG) and stair climbing time (STEP). Moreover, assessment of resting heart rate 
and its responses to an exercise stair challenge and the subsequent prediction of sub- 
maximal oxygen consumption (VO2), an indicator of cardiorespiratory fitness, was also 
similar between groups (Table 2).
Muscle Properties
Electrically induced contractile properties were similar between groups (Table 3). Voluntary 
strength also did not differ between persons with diabetes and controls (p=0.19) and 
maximal activation was achieved in both the diabetes (98.8 + 3.3 %) and control groups 
(99.0 + 1 . 0  %) (p=0.25). However, there was an effect of gender for voluntary strength. 
Men were significantly stronger (40.5 + 2.1 Nm) compared with women (30.3 + 1.7 Nm) 
irrespective of the condition of diabetes. As vigorous activity increased, irrespective of 
gender and diabetic condition, muscle strength also increased (r2 = 0.25).
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Discussion -
This study clearly indicates that muscle strength and functional mobility are not altered 
when co-morbidities are not apparent in persons with type 2  diabetes, and when age-, 
gender-, and PA level are matched to non-diabetic controls muscle strength and functional 
mobility are not altered as a result of hyperglycaemia. As well, irrespective of 
hyperglycaemia the higher the PA scores the greater the muscle strength. These data 
suggest that reductions in functional mobility in persons with type 2  diabetes do not result 
from muscle weakness. Rather, chronic elevation of blood glucose, indicative in this 
sample by elevated HbA1c (8.4 %), likely results in co-morbidities that inevitably influence 
muscle strength and in-turn result in declines in independent function. Results also 
demonstrate the necessity in delineating between genders and defining the activity 
characteristics of both the diabetic and non-diabetic control groups. When gender and PA 
are considered as independent factors women were weaker than men irrespective of the 
diabetic condition, and 25 % of muscle strength was accounted for by increased 
participation in vigorous PA. Thus, PA is a key component to maintaining strength in 
persons with type 2  diabetes, and must be considered when evaluating weakness and 
functional decline in this condition. Longitudinal studies monitoring PA, glucose control and 
co-morbidities associated with type 2  diabetes are warranted in order to fully ascertain 
additional sources that contribute to altering muscle strength and in-turn functional mobility. 
This study also alludes to the necessity of behaviour modification studies in determining 
possible ways to increase the intensity of PA or participation in exercise programs into the 
lifestyle patterns of persons with type 2 diabetes. It seems that persons with type 2
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diabetes are aware of the importance of exercise, but do not utilize this knowledge as a 
method of glucose control.
PA refers to bodily movement produced by the contraction of skeletal muscle that requires 
energy expenditure in excess of resting energy expenditure. Whereas, exercise is 
identified as a subset of PA that is planned and structured and involves repetitive bodily 
movement to improve or maintain any of the components of physical fitness 
(cardiorespiratory, muscular and flexibility) (18). Thus, in this study individuals that 
establish and adhere to a planned exercise program were excluded, and daily PA was 
scored and matched between persons with type 2 diabetes and controls. There is strong 
and consistent evidence that exercise training is beneficial to persons with type 2  diabetes 
(19-21) and this study confirms that persons with type 2 diabetes are aware of the 
importance of exercise but do not utilize this knowledge with structured participation. The 
activity scores are indicative of modest levels of daily PA, and self-report revealed that 
walking was the primary activity of choice. It has been shown that home based training is 
sufficient to maintain strength gains subsequent to a structured and group based exercise 
program, but it was suggested that the intensity declined to a level that resulted in minimal 
influence on glucose control (22). In this study, PA levels where matched between 
persons with and without type 2  diabetes and when this is undertaken lower leg strength is 
similar between groups. However, light activity did not aid in controlling hyperglycaemia in 
persons with type 2  diabetes and it is likely that moderate to heavy intensity PA and/or 
structured exercise would aid in glucose management (23, 24). Thus, practitioners must 
acknowledge and promote that daily PA aids in maintaining strength to a level that is similar 
to controls, but more moderate to vigorous PA, such as participation in a structured
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exercise regime is necessary to aid in glucose control and inevitably delay co-morbidities 
associated with type 2  diabetes.
Blood glucose and glycosylated haemoglobin were ~40 % higher in the diabetic group 
compared with the control. The level of glucose control in the diabetic group was within the 
5.0 -  10.0 mmol/L range that is broadly advised, however the glycosylated haemoglobin 
score was slightly elevated (8.4 %), based upon the <7 % suggested by The Canadian 
Diabetes Association (25). Subjects should attempt to consistently lower blood glucose and 
for longer time periods because elevated HbA1c levels are associated with an increased 
risk of both microvascular and macrovascular complications, (26-29), and hyperglycaemia 
is strongly associated with undetected motor neuropathies (30,31). It is likely that over time 
neuropathies, rather than hyperglycaemia, result in muscle weakness and that the 
inevitable decline in function may be misattributed to a loss of strength.
The dorsi-flexors were chosen because they are functionally relevant to gait and balance 
ability (15, 32, 33) and typically demonstrate early signs of sensory and motor weakness 
relative to the thigh, arm and wrist (30,34). Very few studies have utilized isometric muscle 
strength as a means of determining strength; rather most studies utilize manual muscle 
testing or clinical grading and few studies have utilized isokinetic strength (30,31). Isokinetic 
measures of strength provide a quantifiable measure of dynamic muscle torque, however 
this type of testing requires expensive equipment and the resultant torque is dependent 
upon the speed of the contraction (35, 36) and training or familiarization with the contraction 
is necessary because of the unique nature of the movement (37). Isometric measures of 
force are readily quantified, require minimal equipment with negligible costs, are relatively
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easy to learn and perform (17, 38) and it is well established that maximal force can be 
obtained and the maximal level of activation ensured with the twitch interpolation technique 
(17). With sufficient practise the ability to fully activate muscle and attain MVC is generally 
observed in a variety of conditions (17,38,39). Thus, isometric force is not only a viable 
means to assess muscle strength, but application of the twitch interpolation technique 
shows that individuals with type 2  diabetes were able to fully activate the tibialis anterior. 
These results indicate that the diabetic condition does not preclude maximal force 
production and that when maximal activation is attained muscle strength is similar to age-, 
gender-, PA matched controls.
Contractile properties were also similar between groups. There is substantial literature to 
indicate that in rodent models of streptozotocin induced diabetes there are alterations in 
electrically induced contractile properties (40-42), yet no information is available in persons 
with type 2 diabetes. There is no indication of contractile slowing in this study of middle- 
aged persons with type 2  diabetes, and the tension values are within the natural age- 
related decline for men and women (43, 44). Our human muscle data, unlike many animal 
models indicate that contractile alterations do not occur in the tibialis anterior of persons 
with type 2  diabetes who present with no diagnosed or overt neuropathies.
Women experience a greater number of years in a state of functional dependence as 
compared to men, and this has been associated with loss of muscle mass (45), and it 
seems that this relationship is exacerbated in women with type 2 diabetes (46). This study 
and many others indicate that women are generally weaker than men (5) and thus it is 
imperative to consider gender as an independent factor when assessing strength. Many
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studies that utilize manual muscle testing fail to consider normal variations in strength due 
to this factor as well as age, weight and height (47). When force was normalized to body 
weight in this study women and men with type 2  diabetes did not differ from controls, 
suggesting that the greater decline in functional mobility in women with type 2  diabetes 
does not result from muscle weakness or activation failure. In order to resolve the gender 
issue longitudinal studies are necessary and consideration of the onset of co-morbidities in 
men and women and their associated alterations upon strength must also be taken into 
account.
These data clearly indicate that when daily PA is matched between persons with type 2 
diabetes and non-diabetic controls and gender is delineated, muscle strength does not 
differ suggesting that it is not lower leg weakness that influences the deterioration of 
functional mobility in persons with type 2  diabetes but rather it is more likely associated with 
chronic hyperglycaemia and other associated co-morbidities. Thus, to maintain and/or 
improve functional mobility exercise prescription for persons with type 2  diabetes must be of 
sufficient intensity (moderate-vigorous) to reduce/control hyperglycaemia and other co­
morbidities. This study visibly addresses the necessity of conducting a prospective 
population-based control study evaluating the progressive development of neuropathy in 
relation to participation in PA and hyperglycaemia, where gender is assessed as an 
independent factor in the relationship between muscle strength and functional mobility in 
persons with type 2  diabetes.
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Tables -
Table 1. Anthropometric data of persons with Type 2 diabetes and control individuals. 
Values = mean ± SD.
Type 2 Diabetes Control p value
Age (years) 52.6 ±6.2
(50.5 + 5.5 2 , 54.5 + 6.0 6')
51.7 ±6.9
(49.5 + 7.6 ?, 55.0 + 4.7 <$)
0.73
Weight (kg) 1 0 2 . 0  ±18.6
(93.3 + 16.2 ?, 97.8 + 8 . 8
S)
99.2 ±18.7
(103.4 + 21.9 2, 92.9 + 12.7
6')
0.72
Height (cm) 172.6 ±12.0
(161.5 + 6.9 ?, 175.3 + 3.8
6 )
170.4 ±6.3
(167.5 + 4.9 2, 174.8 + 6.0(2)
0.60
YPAS
(hours/week)
28.8 +_20.3 20.3 +.27.3 0.83
Vigorous Activity 
Score
11.5 + 12.03 19 .5+ 16 .7 0.23
Leisure Index 
Score
16.4 + 15.1 13.2 + 9.2 0.57
Moving Index 
Score
8 .7 +  2.9 9 .0 +  4.0 0.85
Glucose (mmol/L) 
at time of 
strength test
8.33 ±2.21 5.50 ±0.95 0 . 0 0 1
HbA1c (%) 8.4 ±1.3 6.1 ±0.4 0.0000
2
Foot Ulcers n= 0 n= 0 n/a
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Table 2. Functional mobility, balance and daily activity scores. Values = mean ± SD.
Type 2 diabetes Control p value
DSES 6 . 8  ±2.3 n/a n/a
MNSI (%) 30.3 ±12.1 25.2 ±13.2 0.62
Monofilament 
Score (/10)
9.8 ±0.4 9.9 ±0.17 0 . 2 1
Berg Balance 
Scale (%)
94.8 ±3.3 97.6 ±2.0 0.14
TUG (s) 9.5 ±2.2 8 . 8  ±1.3 0.37
Stair Time (s) 85.1 ±14.0 80.4 ±28.8 0.69
Resting heart rate 
(BPM)
72.2 ±9.2 69.9 ±9.4 0.93
Post-Exercise HR 
(BPM)
Normal Pace 
Fast Pace
117.2 ±13.9 
126.0 ±15.8
120.5 ±18.8 
135.7 ±23.3
0.73
0.40
Predicted 
Submaximal V02 
(ml/kg/min)
Normal Pace 
Fast Pace
25.3 ±4.4 
31.1 ±5.1
27.4 ±6.1 
33.2 ±2.4
0.37
0.27
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Table 3. Voluntary and involuntary force results for persons with T2D compared to matched 
controls. Values = mean ± SD.
T2D Control p value
Twitch Contractile
Properties 4.1 ±1.5 3.9 ±1.3 0 . 6 6
Peak Torque (Nm) 94.8±11.3 100.3113.0 0.36
Time to Peak Torque 114.5 ±22.9 105.8 ±20.0 0.49
(ms)
Half-relaxation time
(ms)
MVC
Peak Torque (Nm) 39.6 ±9.6 34.3 ±7.6 0.19
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Figure Legends -
Figure 1: Health related questionnaire scores, as assessed with the SF-36. Persons 
with type 2 diabetes differed from controls (p<0.05) for all variables. Values are 
means + SD.
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